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Abstract
Two commonly used methods for improving precision and power in clinical trials are
stratified randomization and covariate adjustment. Stratified randomization can only
be applied to a limited number of baseline variables, while covariate adjustment can
incorporate information from additional baseline variables. However, many trials do
not fully capitalize on the combined precision gains from these two methods, which can
lead to wasted resources in terms of sample size and trial duration. We derive the large
sample properties (consistency and asymptotic normality) of model-robust estimators
that combine these two methods, and show that these estimators can lead to substantial
gains in precision and power. Our theorems cover a class of estimators that handle
continuous, binary, and time-to-event outcomes; missing outcomes under the missing
at random assumption are handled as well. For each estimator, we give a formula for
a consistent variance estimator that is model-robust and that fully captures variance
reductions from stratified randomization and covariate adjustment. As an example of
our results, we give the first proof (to the best of our knowledge) of the consistency and
asymptotic normality of the Kaplan-Meier estimator under stratified randomization,
and we derive its corresponding asymptotic variance. The above results also hold for
the biased-coin covariate-adaptive design. We demonstrate our results using completed
trial data sets of treatments for substance use disorder, where the variance reduction
due to stratified randomization and covariate adjustment ranges from 1% to 35%.
Keywords: Covariate-adaptive randomization, generalized linear model, robustness.
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1 Introduction
The International Conference on Harmonisation (ICH) guidance on statistical methods for
analyzing clinical trials, which is used by the U.S. Food and Drug Administration and the
European Medicines Agency, states that “Pretrial deliberations should identify those co-
variates and factors expected to have an important influence on the primary variable(s),
and should consider how to account for these in the analysis to improve precision and to
compensate for any lack of balance between treatment groups.” (FDA and EMA, 1998).
More recent regulatory guidance documents also encourage consideration of baseline vari-
ables in order to improve precision in randomized trials (EMA, 2015; FDA, 2019, 2020).
Though there is a rich statistical literature on methods to adjust for baseline variables in
randomized trials that use simple randomization, much less is known for trials that use
other forms of randomization. This is a practical concern since, as discussed below, many
clinical trials use other forms of randomization.
“Covariate-adaptive randomization” refers to randomization procedures that take base-
line variables into account when assigning participants to study arms. The goal is to achieve
better balance across study arms in preselected strata of the baseline variables compared to
simple randomization (which ignores baseline variables). E.g., balance on disease severity,
a genetic marker, or another variable thought to be correlated with the primary outcome
could be sought. The simplest and most commonly used type of covariate-adaptive random-
ization is stratified permuted block randomization (referred to as “stratified randomization”
throughout, for conciseness).
Compared with simple randomization, covariate-adaptive randomization can be advan-
tageous in minimizing imbalance and improving efficiency (Efron, 1971; Pocock and Simon,
1975; Wei, 1978). Due to these benefits, covariate-adaptive randomization has become a
popular approach in clinical trials. According to a survey by Lin et al. (2015), 183 out of
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their sample of 224 randomized clinical trials published in 2014 in leading medical journals
used some form of covariate-adaptive randomization. Stratified randomization (Zelen, 1974)
was implemented by 70% of trials in this survey. Another method for covariate-adaptive
randomization is the biased-coin design by Efron (1971). Other examples include Wei’s urn
design (Wei, 1978) and rerandomization (Morgan and Rubin, 2012). We only consider the
following two types of covariate-adaptive randomization: stratified randomization and the
biased-coin design.
Concerns have been raised regarding how to perform valid statistical analyses at the end
of trials that use covariate-adaptive randomization. Adjusting for stratification variables
is recommended (Lachin et al., 1988; Kahan and Morris, 2012; EMA, 2015), but, accord-
ing to a survey by Kahan and Morris (2012) that sampled 65 published trials from major
medical journals from March to May 2010, 41 implemented covariate-adaptive randomiza-
tion (among which 29 used stratified randomization), but only 14 adjusted in the primary
analysis for the variables used in the randomization procedure. Furthermore, there are few
results on how to conduct the primary efficacy analysis in trials that use stratified ran-
domization without making parametric model assumptions (which, if incorrect, can lead to
bias).
Shao et al. (2010) proved the validity of the two-sample t-test under the biased-coin
design assuming a linear regression model for the outcome given treatment and baseline
variables. Shao and Yu (2013) extended this result to generalized linear models. Both of
the aforementioned methods require correct specification of the regression model.
The asymptotic distribution of the ANCOVA estimator under covariate-adaptive ran-
domization has been derived in several settings. The results of Ma et al. (2015, 2018) require
correct specification of the linear regression model used in the ANCOVA estimator. The
results of Bugni et al. (2018) are robust to arbitrary misspecification of the linear regression
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model, but only apply to linear regression models with main terms for treatment and every
stratum used in the randomization procedure (and cannot include terms for additional base-
line variables). The results of Li and Ding (2019) are robust to arbitrary misspecification
of the linear regression model; however, they use the randomization inference framework
while many clinical trials are analyzed using the superpopulation inference framework (as
done here); see Robins (2002) for a comparison of these frameworks. All of the results in
this paragraph are for the ANCOVA estimator, and so do not apply to logistic regression
models for binary outcomes nor hazard models for time-to-event outcomes. Ye and Shao
(2019) derived asymptotic distributions for log-rank and score tests in survival analysis
under covariate-adaptive randomization; however, estimation was not addressed.
For trials using stratified randomization or the biased-coin design, to the best of our
knowledge it was an open problem to determine (in the commonly used superpopulation
inference framework and without making parametric model assumptions) the large sample
properties of estimators that involve any of the following features: binary or time-to-event
outcomes, adjustment for baseline variables in addition to those in the randomization pro-
cedure, and missing data under the missing at random assumption. This is the problem
that we address, and we think that each of the above features can be important in the
analysis of clinical trials. For example, binary and time-to-event outcomes are commonly
used in clinical trials. According to a survey by Austin et al. (2010) on trials published
in leading medical journals in 2007, 74 out of 114 trials involved binary or time-to-event
outcomes. As we show in our data analyses, the addition of baseline variables beyond those
used for stratified randomization can lead to substantial precision gains. Handling missing
data is also important in order to avoid bias in treatment effect estimation.
Under regularity conditions, we prove that a large class of estimators is consistent
and asymptotically normally distributed in randomized trials that use stratified random-
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ization or the biased-coin design, and we give a formula for computing their asymp-
totic variance. This class of estimators includes, e.g., the ANCOVA estimator for con-
tinuous outcomes, the standardized logistic regression estimator (Scharfstein et al., 1999;
Moore and van der Laan, 2009a) for binary outcomes, the doubly-robust weighted least
squares (DR-WLS) estimator from Marshall Joffe as described by Robins et al. (2007) for
continuous and binary outcomes, and the Kaplan-Meier (K-M) estimator (Kaplan and Meier,
1958) of survival functions and the augmented inverse probability weighted (AIPW) esti-
mator of the restricted mean survival time (Dı´az et al., 2019) for time-to-event outcomes.
Our theorems imply that under standard regularity conditions, whenever an estimator in
our class is consistent and asymptotically normally distributed under simple randomization,
then it is consistent and asymptotically normally distributed under stratified randomization
(or the biased-coin design) with equal or smaller asymptotic variance. Also, its influence
function is the same regardless of whether data is generated under simple randomization,
stratified randomization, or the biased-coin design. This can be advantageous since for
many estimators used to analyze randomized trials, their influence functions have already
been derived under simple randomization. An estimator’s influence function can be input
into our formula (4) to produce a consistent variance estimator under stratified random-
ization and the biased-coin design. (Though the influence function is the same under each
randomization scheme, the asymptotic variance may differ.)
The major challenge to prove asymptotic normality is that data from each partici-
pant are not independent of each other, which results from stratified randomization or the
biased-coin design. For continuous or binary outcomes, the central limit theorem cannot be
directly applied because of this dependence. To overcome this difficulty, we prove asymp-
totic normality based on the empirical process result from Shorack and Wellner (2009),
which was insightfully used by Bugni et al. (2018) to prove their fundamental results for
5
the case described above. For time-to-event outcomes the martingale central limit theorem
is commonly used to prove asymptotic results using the counting process framework, and
this does not require independent observations; unfortunately, a key assumption required
by such theorems (Andersen et al., 2012) are violated under stratified randomization. (See
Section 6 for an explanation.) We instead use empirical process theory (Kosorok, 2008) to
prove asymptotic results for the K-M estimator under stratified or biased-coin randomiza-
tion.
As in the above-referenced work, we assume that the randomization scheme and analy-
sis method have been completely specified before the trial starts, as is typically required by
regulators such as the European Medicines Agency and the U.S. Food and Drug Adminis-
tration (FDA and EMA, 1998; EMA, 2015; FDA, 2019, 2020).
In the next section, we describe three motivating trial examples to which we apply our
methods. In Section 3, we describe our setup, notation and assumptions. We present our
main results in Section 4. In Section 5, we give example estimators for continuous and
binary outcomes to which our general results apply. In Section 6, we present asymptotic
results for estimators involving time-to-event outcomes. Trial applications are provided in
Section 7. Practical recommendations and future directions are discussed in Section 8.
2 Three completed randomized trials that used stratified
randomization
2.1 Study of buprenorphine tapering schedule and illicit opioid use
(NIDA-CTN-0003)
The trial of “Buprenorphine tapering schedule and illicit opioid use”, referred to as “NIDA-
CTN-0003” in the National Drug Abuse Treatment Clinical Trials Network, is a phase-3
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randomized trial completed in 2005 (Ling et al., 2009). The goal was to compare the effects
of a short or long taper schedule after buprenorphine stabilization of patients with opioid
use disorder. Patients were randomized into two arms: 28-day taper (control, 259 patients,
36% missing outcomes) and 7-day taper (treatment, 252 patients, 21% missing outcomes),
stratified by maintenance dose (3 levels) measured at randomization. The outcome of
interest is a binary indicator of whether a participant’s urine tested at the end of the study
is opioid-free. In addition to the stratification variable, we adjust for the following baseline
variables: sex, opioid urine toxicology results, the Adjective Rating Scale for Withdrawal
(ARSW), the Clinical Opiate Withdrawal Scale (COWS) and the Visual Analog Scale
(VAS).
2.2 Prescription Opioid Addiction Treatment Study (NIDA-CTN-0030)
The “Prescription Opioid Addiction Treatment Study”, referred to as “NIDA-CTN-0030” is
a phase-3 randomized trial completed in 2013 (Weiss et al., 2011). The goal is to determine
whether adding individual drug counseling to the prescription of buprenorphine/naloxone
will improve treatment outcomes for patients with prescription opioid use disorder. Though
this study adopted a 2-phase adaptive design, we focus on phase I, where patients were ran-
domized into standard medical management (control, 330 patients, 10% missing outcomes)
or standard medical management plus drug counseling (treatment, 335 patients, 13% miss-
ing outcomes). Randomization is stratified by the presence or absence of a history of heroin
use and current chronic pain, resulting in 4 strata. The outcome of interest is the propor-
tion of negative urine laboratory results among all tests. Among all 5 urine laboratory
tests during the first 4 weeks of phase I, if a patient missed visits of more than 2 weeks,
the outcome is regarded as missing. Baseline variables that are included in the analysis are
randomization stratum, age, sex and urine laboratory results.
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2.3 Study of internet-delivered treatment for substance abuse (NIDA-
CTN-0044)
The phase-3 randomized trial “Internet-delivered treatment for substance abuse”, referred
to as “NIDA-CTN-0044”, was completed in 2012 (Campbell et al., 2014). The goal was to
evaluate the effectiveness of a web-delivered behavioral intervention, Therapeutic Education
System (TES), in the treatment of substance abuse. Participants were randomly assigned
to two arms: treatment as usual (control, 252 participants, 19% missing outcomes) and
treatment as usual plus TES (treatment, 255 participants, 18% missing outcomes). Ran-
domization was stratified by treatment site, patient’s primary substance of abuse (stimulant
or non-stimulant) and abstinence status at baseline. Since we do not have access to the
treatment site variable, only the patient’s primary substance of abuse and abstinence sta-
tus at baseline were included as strata (4 levels) in our analysis; treatment site was not
used. After randomization, each participant was followed for 12 weeks with 2 urine lab-
oratory tests per week. The outcome of interest is the proportion of negative urine lab
results among all tests. If a participant missed visits of more than 6 weeks, the outcome
is regarded as missing. We adjust for randomization stratum and the following additional
baseline variables: age, sex and urine laboratory result. Another outcome of interest is the
time to abstinence, defined as the time to first two consecutive negative urine tests during
the study. Censoring time is defined as the first missing visit. For demonstration, we use
the data of the first 6 weeks in the data analysis of the time-to-event outcome, during which
99% of the events occurred.
In some cases, the outcomes in our analyses differ from the primary outcomes in the
corresponding trials. The reason is that we wanted to use the same outcomes across trials
for illustration. Our outcomes are all considered important in the field of substance use
disorder treatments.
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3 Definitions and assumptions
3.1 Data generating distributions
We focus on randomized trials that use stratified randomization (or the biased-coin design)
with n participants. For each participant i = 1, . . . , n, let Yi denote the primary outcome,
Mi denote whether Yi is non-missing (Mi = 1) or missing (Mi = 0), Ai denote study
arm assignment (Ai = 1 if assigned to treatment and Ai = 0 if assigned to control), and
X i denote a vector of baseline covariates. This notation is for real-valued outcomes, e.g.
continuous or binary outcomes. Modified definitions, assumptions, and results for time-to-
event outcomes are given in Section 6.
We use the Neyman-Rubin potential outcomes framework, which assumes the existence
of potential outcomes Yi(0) and Yi(1) for each participant i. These represent the outcome
that would be observed under assignment to study arm 0 or 1, respectively. Though using
potential outcomes introduces additional notation, it is needed in order to rigorously define
the data generating distributions under the different randomization procedures that we
consider. We make the following consistency assumption linking the observed outcome Yi
to the potential outcomes: Yi = Yi(Ai) = Yi(1)A1 + Yi(0)(1 − Ai) for each participant i.
Also, letMi(a) be the indicator of whether participant i would have a non-missing outcome
if they get assigned to study arm a ∈ {0, 1}. We assume, analogous to the consistency
assumption above, that Mi =Mi(Ai).
For each participant i, we define the full data vector (including potential outcomes,
some of which are not observed) W i = (Yi(1), Yi(0),Mi(1),Mi(0),X i) and the observed
data vector Oi = (Ai,Xi, YiMi,Mi) for real-valued outcomes. The reason that the product
YiMi appears in the observed data vector Oi is to encode that whenever the outcome is
missing (Mi = 0), the outcome value Yi is not available in Oi (since YiMi = 0). The data
available to the analyst at the end of the trial are O1, . . . ,On.
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We make the following assumptions on the distribution of {W 1, . . . ,W n}:
Assumption 1.
(i)W i, i = 1, . . . , n are independent, identically distributed samples from an unknown
joint distribution P on W = (Y (1), Y (0),M(1),M(0),X ).
(ii) Missing at random (MAR): M(a)⊥⊥Y (a)|X for each arm a ∈ {0, 1}, where ⊥⊥
denotes independence.
Throughout this paper, we use E to denote the expectation with respect to distribution
P .
3.2 Randomization procedures: simple, stratified, and biased-coin
Simple randomization assigns study arms A1, . . . , An by independent Bernoulli draws each
with probability pi of being 1, e.g., using a random number generator. By design, the
draws are independent of each other and of all participant characteristics measured before
randomization or not impacted by randomization. Therefore, we have that (A1, . . . , An) is
independent of (W 1, . . . ,W n).
For stratified randomization or the biased-coin design, treatment allocation depends on
predefined baseline strata, such as gender, age, location, disease severity, or a combinations
of these. We refer to the predefined baseline strata that are used in the randomization
procedure as “randomization strata”. The baseline stratum of participant i is denoted
by the single, categorical variable Si taking K possible values; it is encoded using K − 1
dummy variables that make up the first k − 1 components of the baseline covariate vector
X . For example, if randomization strata are defined by 4 sites and a binary indicator of
high disease severity, then S has K = 8 possible values. We denote Si as the stratification
variable for participant i and S the set of all K randomization strata. The goal of stratified
randomization or the biased-coin design is to achieve “balance” in each stratum; that is,
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the proportion of participants assigned to the treatment arm is targeted to a prespecified
proportion pi ∈ (0, 1), e.g. pi = 0.5.
Stratified randomization uses permuted blocks to assign treatment. In each stratum,
a randomly permuted block with fraction pi 1’s (representing treatment) and (1 − pi) 0’s
(representing control) is used for sequential allocation. When a block is exhausted, a new
block is used.
The biased-coin design can be applied when pi = 0.5 and it allocates participants se-
quentially by the following rule for k = 1, . . . , n:
P (Ak = 1|S1, . . . , Sk, A1, . . . , Ak−1) =


0.5, if
∑k−1
i=1 (Ai − 0.5)I{Si = Sk} = 0
λ, if
∑k−1
i=1 (Ai − 0.5)I{Si = Sk} < 0
1− λ, if ∑k−1i=1 (Ai − 0.5)I{Si = Sk} > 0
where λ ∈ (0.5, 1] and I{Z} is an indicator function which equals 1 if Z is true and 0
otherwise. Our results for the biased-coin design only apply to the case of pi = 1/2.
When comparing the three types of randomization procedures (simple, stratified, or
biased-coin), we assume that all use the same value of pi. For the stratified randomiza-
tion and biased-coin designs, it follows by construction (and was shown by Bugni et al.,
2018) that (W 1, . . . ,W n)⊥⊥(A1, . . . , An)|(S1, . . . , Sn); that is, the study arm assignments
(A1, . . . , An) are conditionally independent of the participant baseline variables and po-
tential outcomes (W 1, . . . ,W n) given the randomization strata (S1, . . . , Sn). Intuitively,
this is because the study arm assignment procedure only has access to the participants’
randomization strata (and nothing else about the participants). Furthermore, these two
designs and Assumption 1 (i) imply that
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1√
n
n∑
i=1
(Ai − pi)I{Si = s}|(S1, . . . , Sn) d−→ 0 a.s.
Under any of the three randomization procedures, each observed data vector Oi =
(Ai,X i, YiMi,Mi) is identically distributed. Let P
∗ denote this distribution, i.e., the
distribution of a generic, observed data vector (A,X , Y M,M). This distribution is the
same for each of the three randomization procedures, and is that induced by first draw-
ing a single realization W = (Y (1), Y (0),M(1),M(0),X ) from the distribution P (see
Assumption 1), then drawing A as an independent Bernoulli draw with probability pi of
being 1, and lastly applying the consistency assumptions Y = Y (1)A + Y (0)(1 − A) and
M =M(1)A +M(0)(1 −A) to construct Y , the (non)-missingness indicator M , and their
product YM . The corresponding expectation with respect to P ∗ is denoted E∗, which is
used below.
3.3 Targets of Inference (Estimands) and Estimators
For continuous and binary outcomes, our goal is to estimate a population parameter ∆∗,
which is a contrast between the marginal distributions of Y (1) and Y (0). For example,
the parameter of interest can be the population average treatment effect, defined as ∆∗ =
E[Y (1)] − E[Y (0)]. We assume that the estimator of ∆∗ is an M-estimator and can be
expressed as a solution to estimating equations of the form:
n∑
i=1
ψ(Ai,X i, Yi,Mi;θ) = 0, (1)
where ψ is a column vector of known functions with dimension p + 1, θ = (∆,βt)t is a
column vector of parameters with dimension p + 1 and β is a column vector of nuisance
parameters with dimension p. We denote the solution to equation (1) as θ̂ = (∆̂, β̂
t
)t. Then
∆̂ is regarded as the estimator of ∆∗. Many estimators used in clinical trials, including all
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estimators defined in Section 5, can be expressed as solutions to estimating equations (1)
for an appropriately chosen vector of estimating functions ψ. We assume that ψ does not
involve any missing outcomes (since then the corresponding estimating equations could not
be solved using the observed data), i.e., we assume that ψ(A,X , Y,M) can be expressed
as a function of A,X , Y M,M .
For time-to-event outcomes, the K-M estimator of the survival curve is commonly used.
Since it is not an M-estimator, our general result (Theorem 1) for M-estimators below does
not apply. We separately prove analogous results for the K-M estimator as described in
Section 6.
We assume regularity conditions similar to the classical conditions that are used for
proving consistency and asymptotic linearity of M-estimators for independent, identically
distributed data, as given in Section 5.3 of van der Vaart (1998). One of the conditions is
that the expectation of the estimating equations
E∗[ψ(A,X , Y,M ;θ)] = 0 (2)
has a unique solution in θ, which is denoted as θ = (∆,βt)t. The other regularity conditions
are given in the Supplementary Material.
Results in Section 5.3 of van der Vaart (1998) imply that under simple randomiza-
tion, given Assumption 1 and the regularity conditions in the Supplementary Material, ∆̂
converges in probability to ∆ and is asymptotically normally distributed with asymptotic
variance that we denote by V˜ . We focus on determining what happens under stratified
randomization or the biased-coin design, where our main result (Section 4) is that consis-
tency and asymptotic normality still hold but the asymptotic variance may be smaller (and
a consistent variance estimator is given).
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4 Main result
Consider the setup in Section 3.3, where the M-estimator ∆̂ is defined.
Theorem 1. Given Assumption 1 and regularity conditions in the Supplementary Material,
under simple randomization, stratified randomization or the biased-coin design, we have
√
n(∆̂−∆) = 1√
n
n∑
i=1
IF (Ai,X i, Yi,Mi) + op(1), (3)
where IF (Yi,Mi, Ai,Xi) is the first entry of −B−1ψ(Ai,X i, Yi,Mi;θ) with
B = E∗
[
∂
∂θψ(A,X , Y,M ;θ)
∣∣∣
θ=θ
]
.
Furthermore, for stratified randomization and the biased-coin design,
√
n(∆̂ − ∆) d−→
N(0, V ) with
V = V˜ − 1
pi(1− pi)E
∗
[
E∗ {(A− pi)IF (A,X , Y,M)|S}2
]
(4)
where V˜ is the asymptotic variance under simple randomization. V can be consistently
estimated using the observed data as described in the Supplementary Material.
Theorem 1 implies that given our setup and assumptions, whenever an M-estimator
∆̂ is consistent and asymptotically normally distributed under simple randomization, then
it is consistent and asymptotically normally distributed under stratified randomization
(or the biased-coin design) with equal or smaller asymptotic variance. Also, its influence
function is the same regardless of whether data is generated under simple randomization,
stratified randomization, or the biased-coin design; this can be advantageous since for
many estimators used to analyze randomized trials, their influence functions have already
been derived under simple randomization. The last display in Theorem 1 gives a simple
formula for calculating the asymptotic variances for these estimators under the other two
randomization schemes, in terms of the influence function.
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For the unadjusted estimator, our Theorem 1 is equivalent to Theorem 4.1 of Bugni et al.
(2018) under stratified randomization or the biased-coin design. In the special case of con-
tinuous outcomes, if the ANCOVA estimator is used with X = S, then Theorem 1 is
equivalent to the result in section 4.2 of Bugni et al. (2018) under stratified randomization
or the biased-coin design, though their results also handle other types of covariate-adaptive
randomization. Our proof relies on a generalization of Lemmas 1 and 2 in the Supple-
mentary Material from Bugni et al. (2018) that is based on the empirical process result of
Shorack and Wellner (2009).
Theorem 1 above extends the results of Bugni et al. (2018) to handle the class of M-
estimators, that is, estimators calculated by solving estimating equations (1). This class
of estimators includes the following: the ANCOVA estimator with covariates in addition
to those used in the randomization procedure (Example 1 of Section 5 below), the stan-
dardized logistic regression estimator (Example 2 of Section 5), the inverse-probability-
weighted estimator (IPW, Robins et al., 1994), the augmented inverse probability weighted
(AIPW, Moore and van der Laan, 2009b) estimator, the DR-WLS estimator (Example 3 of
Section 5), the Mixed-effects Model for Repeated Measures (MMRM, Mallinckrodt et al.,
2003; Siddiqui et al., 2009; EMA, 2019) estimator, among others. Thus, Theorem 1 cov-
ers estimators that handle various outcome types, repeated measures outcomes, missing
outcome data, and covariate adjustment.
We next give the proof sketch for Theorem 1. The first step is to show equation (3) holds
under each of the following data generating distributions: stratified randomization, the
biased-coin design, and simple randomization. The influence function IF (Ai,Xi, Yi,Mi) is
the same in all three cases, and depends only on the criterion function ψ, the distribution
P on the vector W (which is not impacted by the randomization procedure), and pi.
The second step is to prove asymptotic normality and derive the asymptotic variance
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of the estimator under stratified randomization and the biased-coin design. This is more
complicated than under simple randomization (where each participant’s data is an inde-
pendent draw from P ∗) because the data from different participants are not independent.
Our proof is based on the empirical process results from Shorack and Wellner (2009).
In the third step, we estimate the asymptotic variance V using the empirical distribution
of observed data Pn, i.e.
V̂ = V˜n − 1
pi(1− pi)En
[
En[(A− pi)IF (A,X , Y,M)|S]2
]
, (5)
where V˜n is the sandwich variance estimator of ∆̂ (Section 3.2 of Tsiatis, 2007), defined as
the first-row first-column entry of
1
n
{
En
[
∂
∂θ
ψ(A,X , Y,M ;θ)
∣∣∣∣
θ=θ̂
]}−1 {
En
[
ψ(A,X , Y,M ; θ̂)ψ(A,X , Y,M ; θ̂)t
]}
{
En
[
∂
∂θ
ψ(A,X , Y,M ;θ)
∣∣∣∣
θ=θ̂
]}−1,t
and En denotes expectation with respect to Pn. Using a similar technique as in step two,
we establish the consistency of V̂ to V .
5 Examples of estimators for continuous and binary out-
comes
5.1 ANCOVA, Standardized Logistic Regression, and DR-WLS Estima-
tors
We give several examples of estimators that our theorem above applies to. For estimators
defined in Examples 1-3, the parameter of interest, i.e. ∆∗, is the average treatment effect
defined as E[Y (1)] − E[Y (0)], and we denote Zi = (1, Ai,Xti)t. In Examples 1 and 2,
we assume no missing data. We do not assume that the working models, i.e., the linear
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regression model in Example 1 and the logistic regression model in Example 2, are correctly
specified.
Example 1. For continuous outcomes, the ANCOVA estimator ∆̂ancova for ∆
∗ involves
first fitting a linear regression working model E[Y |A,X ] = β0+βAA+βtXX using ordinary
least squares and then letting ∆̂ancova be the estimate of βA. The ANCOVA estimator can
be equivalently calculated by solving estimating equations (1) letting
ψ(Ai,Xi, Yi,Mi;θ) =

 βA −∆
{Yi − (β0 + βAAi + βtXXi)}Zi

 .
Example 2. For binary outcomes, the standardized logistic regression estimator ∆̂logistic
is calculated by first fitting a working model: P (Y = 1|A,X) = expit(β0 + βAA+ βtXX),
where expit(x) = 1/(1+e−x), and getting the maximum likelihood estimates (β̂0, β̂A, β̂
t
X)
t.
Then define
∆̂logistic =
1
n
n∑
i=1
{expit(β̂0 + β̂A + β̂
t
XXi)− expit(β̂0 + β̂
t
XX i)}.
The estimator ∆̂logistic can be equivalently calculated by solving estimating equations (1)
letting
ψ(Ai,X i, Yi,Mi;θ) =

 expit(β0 + βA + βtXXi)− expit(β0 + βtXX i)−∆
{Yi − expit(β0 + βAAi + βtXXi)}Z i

 .
This estimator is mentioned as potentially useful in COVID-19 treatment and prevention
trials in the FDA guidance (FDA, 2020). Another estimator is the logistic coefficient
estimator, defined as β̂A. Unlike the standardized logistic regression estimator, the logistic
coefficient estimator estimates a conditional effect and can lead to invalid inference if there
is treatment effect heterogeneity. A detailed comparison of the two estimators can be found
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in Steingrimsson et al. (2016). We hence do not consider the logistic coefficient estimator
in this paper.
Example 3. When some outcomes are missing, one can estimate ∆∗ by the DR-WLS
estimator, which generalizes the estimators in Examples 1 and 2. The estimator is calculated
by the following steps. First, fit the logistic regression working model:
P (M = 1|A,X) = expit(α0 + αAA+αtXX) (6)
and get the maximum likelihood estimates (α̂0, α̂A, α̂
t
X)
t of parameters (α0, αA,α
t
X
)t. Here
we assume positivity, i.e., P (M = 1|a,x) > 0 for all (a,x) in the support of (A,X). Next,
fit the following working model for the outcome given study arm and baseline variables
(from the generalized linear model family):
E[Y |A,X ] = g−1(β0 + βAA+ βtXX) (7)
with weights 1/expit(α̂0 + α̂AAi + α̂
t
XX i) using only the data with Mi = 1. Here the
inverse link function is g−1(x) = x for continuous outcomes and g−1(x) = expit(x) for
binary outcomes. Third, the DR-WLS estimator is
∆̂DR−WLS =
1
n
n∑
i=1
{Ê[Y |A = 1,X i]− Ê[Y |A = 0,X i]}.
Third the DR-WLS estimator can be equivalently calculated by solving estimating equations
(1) with
ψ(Ai,X i, Yi,Mi;θ) =


{g−1(β0 + βA + βtXXi)− g−1(β0 + βtXXi)} −∆
Mi
expit(α0+αAAi+αtXXi)
{Yi − g−1(β0 + βAAi + βtXXi)}Z i
{Mi − expit(α0 + αAAi +αtXX i)}Zi


.
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The ANCOVA estimator and the standardized logistic regression estimator are special cases
of the DR-WLS estimator. If there are no missing data, which means Mi ≡ 1 for a = 0, 1
and i = 1, . . . , n, and the regression weights used to fit (7) are constant, then ∆̂DR−WLS
reduces to ∆̂ancova for continuous outcomes and to ∆̂logistic for binary outcomes.
5.2 Asymptotic Results for Estimators in Examples 1-3
Theorem 1 applies to the estimators in Examples 1-3 since each is an M-estimator. In par-
ticular, under the conditions in the theorem, the asymptotic variance of each estimator can
be consistently estimated by the formula (var. formula from theorem 1). Furthermore, un-
der additional conditions listed in the corollary below, we can say even more; specifically,
the asymptotic variance of each estimator in Examples 1-3 is the same and consistently
estimated by the sandwich variance estimator V˜n regardless of whether simple randomiza-
tion, stratified randomization, or the biased-coin design is used. Under such conditions, the
estimators and their corresponding sandwich variance estimators can be used to perform
hypothesis tests and construct confidence intervals that are asymptotically correct.
Corollary 1. For the ANCOVA estimator, standardized logistic regression estimator and
DR-WLS estimator, we assume their estimating equations satisfy Assumption 1 and reg-
ularity conditions in the Supplementary Material. For the DR-WLS estimator, we fur-
ther assume at least one of the two working models (6) and (7) is correctly specified, and
P (M = 1|a,x) > 0 for all (a,x) in the support of (A,X). If (1) pi = 0.5, or (2) the outcome
regression model includes treatment-by-randomization-strata interaction terms, or (3) the
outcome regression model is correctly specified, then under simple randomization, stratified
randomization or the biased-coin design, these estimators are consistent and asymptotically
normally distributed with asymptotic variance V = V˜ . Furthermore, the sandwich variance
estimator is consistent.
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6 Estimators involving time-to-event outcomes
6.1 Notation and Assumptions
For time to event outcomes, we use slightly modified notation and assumptions compared
to that above. We assume that the outcome is right-censored and that we observe either
the failure (event) time or the censoring time, whichever occurs first. Let Yi denote the
failure time and Mi denote the censoring time. Other variables including Ai,Xi and the
potential outcomes Yi(a),Mi(a) for a = 0, 1 are defined as in Section 3. For each participant
i ∈ {1, . . . , n}, we observe (Ai,X i, Ui, δi), where Ui = min{Yi,Mi} and δi = I{Yi ≤ Mi}.
We further define a restriction time τ such that the time window t ∈ [0, τ ] is of interest. We
define P ∗ and E∗ analogously as in Section 3.2, except here they represent the distribution
and expectation, respectively, for a single observed data vector (A,X , U, δ).
The following assumption is made in place of Assumption 1:
Assumption 1’.
(i’)W i, i = 1, . . . , n are independent, identically distributed samples from an unknown
joint distribution P on W = (Y (1), Y (0),M(1),M(0),X ).
(ii’) Censoring completely at random: M(a)⊥⊥Y (a) for each arm a ∈ {0, 1}.
(iii’) P (min{Y (a),M(a)} > τ) > 0 for a = 0, 1.
Compared with Assumption 1, Assumption 1’ (i’) is the same as Assumption 1 (i), and
Assumption 1’ (ii‘) assumes censoring completely at random instead of missing at random.
This modification of assumptions on the missing mechanism is because we consider the K-M
estimator and its consistency generally requires Assumption 1’ (ii’). Assumption 1’ (iii‘) is
often made in survival analysis, which states that there is a positive probability that both
the failure time and censoring time occur after τ .
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6.2 Kaplan-Meier estimator under simple, stratified, and biased-coin
randomization
One commonly-used method for survival analysis is the K-M estimator. The goal is to
estimate the survival curve {S(a)0 (t) : t ∈ [0, τ ]} for each a = 0, 1 where S(a)0 (t) = P (Y (a) >
t). This represents the survival curve if everyone in the study population were to be assigned
to study arm a. The K-M estimator is defined as
Ŝ(a)n (t) =
∏
j:Tj≤t
(
1−
∑n
i=1 δiI{Ai = a}I{Ui = Tj}∑n
i=1 I{Ai = a}I{Ui ≥ Tj}
)
,
where {Tj , j = 1, . . . ,mn} is the list of unique observed failure times. Since the K-M
estimator estimates a survival function rather than a real number or a vector, our Theorem 1
on M-estimators does not apply. The following theorem gives the asymptotic distribution
of the K-M estimator under different types of randomization.
Theorem 2. Given Assumption 1’, under simple randomization, stratified randomization
or the biased-coin design, we have
√
n(Ŝ(a)n (t)− S(a)0 (t)) =
1√
n
n∑
i=1
IF (a)(Ai, Ui, δi; t) + op∗(1), (8)
where the influence function IF (a)(Ai, Ui, δi; t) is defined in the Supplementary Material and
op∗(1) represents a sequence of random variables that converges to 0 in probability uniformly
over t ∈ [0, τ ].
Furthermore, for stratified randomization and the biased-coin design, the process
{√n(Ŝ(a)n (t) − S(a)0 (t)) : t ∈ [0, τ ]} converges weakly to a mean 0, tight Gaussian process
with covariance function V (a)(t, t′) defined in the Supplementary Material. For any t ≤ τ ,
we have
V (a)(t, t) = V˜ (a)(t, t)− 1
pi(1− pi)E
∗
[
E∗
{
(A− pi)IF (a)(A,U, δ; t)|S
}2]
,
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where V˜ (a)(t, t) is the asymptotic variance under simple randomization. V (a)(t, t) can be
consistently estimated as described in the Supplementary Material.
Analogous to Theorem 1, Theorem 2 implies that the influence function of the K-M
estimator is the same under simple randomization, stratified randomization and the biased-
coin design. Under simple randomization, the influence function for the K-M estimator had
been derived by Reid (1981) for continuous survival functions and Kosorok (2008, Section
4.2) for survival functions that may have jumps.
The above theorem implies that under stratified randomization or the biased-coin de-
sign, the K-M estimator is consistent and asymptotically normally distributed with equal or
smaller asymptotic variance than under simple randomization. The asymptotic covariance
function of the K-M estimator under stratified randomization or the biased-coin design is
given in Appendix C of the Supplementary Material. It can be used to construct pointwise
confidence intervals and a simultaneous confidence band.
The challenge in proving Theorem 2 is that the traditional tool for deriving asymptotic
normality in survival analysis, i.e., martingale central limit theorems such as Theorem II.5.1
of Andersen et al. (2012) or Theorem 5.1.1 of Fleming and Harrington (2011), is not appli-
cable here because of the dependence among data points introduced by stratified random-
ization or the biased-coin design. To illustrate this, for participant i, let Ni = {Ni(t) : t ∈
[0, τ ]} = {I{Ui ≤ t, δi = 1} : t ∈ [0, τ ]} be the observed failure counting process and Λi(t)
be the corresponding cumulative hazard function. Under simple randomization and inde-
pendent right censoring, the process Mn = {
∑n
i=1Ni(t)−
∑n
i=1
∫ t
t′=0 I{Yi ≥ t′}dΛi(t′) : t ∈
[0, τ ]} is a martingale given filtration F (n)t = σ{Ni(s), I{Ui ≤ s} : s ∈ [0, t], i = 1, . . . , n}, to
which a martingale central limit theorem can be applied. When N1, . . . , Nn are correlated,
however, Mn may no longer be a martingale given filtration F (n)t . To illustrate this phe-
nomenon, consider an example with n = 2 participants, no censoring, τ = 0.5, and event
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times defined by Y1 = − logU and Y2 = − log(1 − U) where U is uniformly distributed
on [0, 1]. Then Y1 and Y2 are dependent with each (marginally) having standard exponen-
tial distribution, i.e., Λ1(t) = Λ2(t) = t for each t ≥ 0. Direct calculation gives that for
any 0 < t′ < t ≤ τ , E[M2(t) −M2(t′)|F (2)t′ ] equals t′ − t if min{Y1, Y2} ≤ t′ and equals
(t′ − t)(2 − 2e−t′)/(1 − 2e−t′) otherwise. In either case, the conditional expectation is not
equal to 0 showing that M2 is not a martingale.
To overcome the above difficulty, in the proof of Theorem 2, we first developed a central
limit theorem for dependent processes under stratified randomization (Lemma 4 in the
Supplementary Material) using empirical process results by Shorack and Wellner (2009)
and then proved our results following similar lines of argument as the proof of Theorem 1.
We conjecture that, using our central limit theorem for dependent process, Theorem 2
can be generalized to other estimators of survival functions, such as the covariate-adjusted
estimators proposed by Zhang (2015); Lu and Tsiatis (2011), which may improve precision
even further.
6.3 Other estimators for time-to-event outcomes
Another parameter of interest is the restricted mean survival time, defined as ∆∗ =
E[min{Y (1), τ} − min{Y (0), τ}]. One estimator of the restricted mean survival time is
the augmented inverse probability weighted (AIPW) estimator (Moore and van der Laan,
2009b). This estimator is an M-estimator, to which our Theorem 1 applies to. When
the survival rate at a given time point is the parameter of interest, one can use the K-M
estimator or the method from Benkeser et al. (2020).
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7 Clinical trial applications
Table 1 summarizes our data analyses for each application (NIDA-CTN-0003, NIDA-CTN-
0030, NIDA-CTN-0044). All missing baseline values were imputed by the median for con-
tinuous variables and mode for binary or categorical variables. When implementing the AN-
COVA estimator or standardized logistic regression estimator, all participants with missing
outcomes were removed from the analysis. Estimates and standard errors are rounded to
the nearest 0.01. “Confidence Interval” is abbreviated as “CI”. For all of the three trials,
negative (positive) estimates are in the direction of clinical benefit (harm).
Table 1: Summary of clinical trial data analyses. The first column is the study ID. The second col-
umn gives the estimator with 95% confidence intervals (CI) adjusting for randomization strata only.
The third column gives the estimator with 95% confidence intervals (CI) adjusting for randomiza-
tion strata and additional baseline variables. The fourth column gives the DR-WLS estimator with
95% confidence intervals (CI) adjusting for randomization strata and additional baseline variables.
The fifth column shows the variance reduction due to adjustment for additional baseline variables
comparing the second and third columns. For the second and third columns, the standardized lo-
gistic regression estimator was used for NIDA-CTN-0003 and the ANCOVA estimator was used for
NIDA-CTN-0030 and NIDA-CTN-0044.
Study
Estimator adjusting
for randomization strata only
(95% CI)
Estimator adjusting
for all baseline variables
(95% CI)
DR-WLS
estimator
(95% CI)
Proportional
variance
reduction
NIDA-CTN-0003 -0.11(-0.21, -0.01) -0.10(-0.19, -0.02) -0.10(-0.18, -0.02) 35%
NIDA-CTN-0030 0.02(-0.02, 0.05) 0.01(-0.02, 0.05) 0.01(-0.02, 0.05) 17%
NIDA-CTN-0044 -0.09(-0.14, -0.03) -0.09(-0.14, -0.03) -0.09(-0.15, -0.03) 2%
For NIDA-CTN-0003, the standardized logistic regression estimator was used since the
outcome was binary. If randomization strata were adjusted only, the estimated absolute
risk difference of getting negative urine lab result was −0.11 with 95% CI (−0.21,−0.01);
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if randomization strata as well as additional baseline variables were adjusted, the point es-
timate became −0.10 with 95% CI (−0.19,−0.02). Though the point estimates are similar,
the variance reduction due to adjusting for additional baseline variables is 35%, indicating
that researchers planning to perform adjustment for randomization strata and additional
baseline variables could achieve the same precision as adjusting for randomization strata
only with approximately 35% fewer participants. The DR-WLS estimate was −0.10 with
95% CI (−0.18,−0.02), which is similar to the estimator adjusting for additional baseline
variables.
NIDA-CTN-0030 and NIDA-CTN-0044 had continuous outcomes and the ANCOVA es-
timator was used. Adjustment for additional baseline variables brings 17% and 2% variance
reduction for NIDA-CTN-0030 and NIDA-CTN-0044, respectively, compared to adjusting
only for the randomization strata. When additional baseline variables are not strongly
prognostic, such as in NIDA-CTN-0044, the variance reduction from additional baseline
variables can be small.
Figure 1 presents the K-M estimator for time-to-abstinence as defined in Section 2.3.
We estimated the variance of the K-M estimator in two different ways: one ignores the
stratification variable and was outputted by the standard statistical software (e.g., the
“survfit” function in R) and the other one used our proposed variance formula that takes
the stratification into account. For each of the two variance estimators, we constructed
the corresponding point-wise confidence intervals of the K-M estimator. While Figure 1
shows that confidence intervals based on different variance estimators are very close to
each other, there are variance reductions due to accounting for stratification, which can be
translated into sample size reduction. The variance reduction ranges from 1% to 12% for
the treatment group and from 4% to 15% for the control group as we consider the survival
function at different time points. Among all time points, the first time point (one week
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after randomization) has the greatest variance reduction. Our findings are consistent with
the result of Theorem 2.
Figure 1: The K-M estimator of survival functions of NIDA-CTN-0044 treatment group
(A) and control group (B). Dashed (dot-dashed) lines represent the estimates and confi-
dence intervals if stratified randomization were (not) ignored in data analyses. “Variance
Reduction” and the associated percentages represent the variance reduction by correcting
the variance formula at each time point.
8 Discussion
There is potential to substantially improve precision by adjusting for additional baseline
variables than the ones used in the randomization procedure. For example, for NIDA-
CTN-0003 and NIDA-CTN-0030, adjustment for additional baseline variables brings 35%
and 17% variance reduction respectively. Our results show that there is no problem to
implement this, and that many estimators used in randomized trials are consistent, asymp-
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totically normal with variance that can be consistently estimated using our formula in
Theorem 1. This asymptotic variance may be less than in the simple randomization case,
and our variance formula captures any added precision gain from stratified randomization
(asymptotically). Furthermore, we provide R functions to calculate the variance for com-
mon estimators including Examples 1-3 and the K-M estimator, which are available at
https://github.com/BingkaiWang/covariate-adaptive.
The key to improving precision is adjusting for strongly prognostic baseline variables, if
they exist. At the outset, one could use previous trials or observational data from a similar
population to measure the prognostic value added by a set of baseline variables. This can
be done by fitting two models, with one adjusting for the set of baseline variables and the
other one not, and comparing their sandwich variance estimates.
Our asymptotics, as essentially all asymptotic results under the commonly used super-
population inference framework, assume that the number of randomization strata is fixed
and the number of participants in each stratum goes to infinity. (We assume the same
for the number of additional baseline variables.) This may be a reasonable approximation
when no stratum has a small number of participants. In our data examples, the smallest
stratum has 49 participants. An area of future research is to consider cases where some
randomization strata have few participants.
In our data analysis of NIDA-CTN-0044, the stratification variable “treatment site”
was not available in our data set. It was therefore neither used in the estimator nor in
the corresponding variance estimate. The variance estimator (5) in this case is asymptot-
ically conservative. This is because the outer expectation in the rightmost term of (4) is
unchanged or decreased if S is replaced by a coarsening of S (defined as merging several
randomization strata together in a preplanned way, in the analysis); this follows from the
conditional Jensen’s inequality. This result may be useful more generally, e.g., when some
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strata are so small compared to the sample size that stratum-specific evaluation of the
empirical means En in (5) cannot be reliably done. In such cases a pre-planned, coarsened
stratum indicator could be used and the resulting hypothesis test would still control Type
I error, asymptotically.
Stratified randomization is related to stratified sampling designs, also called “two-phase
sampling” (Sen, 1988; Breslow and Wellner, 2007; Bai et al., 2013). To the best of our
knowledge, asymptotic results for these designs do not directly apply to our problem; a key
difference is that asymptotic results for stratified sampling designs often involve finite pop-
ulation inference (commonly used in survey sampling), while here we use superpopulation
inference (commonly used in analyzing randomized trials).
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In Section A, we give the regularity conditions in Theorem 1. In Section B, we present
consistent estimators of the asymptotic variance V defined in Theorem 1. In Section C,
we define the asymptotic variance V (a)(t, t′), which is described in Theorem 2, and pro-
vide a consistent estimator for V (a)(t, t). In Section D, we give the proofs of Theorem 1
(Section D.1), Corollary 1 (Section D.2) and Theorem 2 (Section D.3).
A Regularity conditions in Theorem 1
We denote the Euclidean norm as || · ||, which means ||x|| =
√
xtx for any x in a Euclidean
space. The regularity conditions for Theorem 1, which are similar to those used in Section
1
5.3 of van der Vaart (1998) in their theorem on asymptotic normality of M-estimators (for
independent, identically distributed data), are given below:
(1) θ ∈ Θ, a compact set in Rp+1.
(2) E[||ψ(a,X, Y (a),M(a); θ)||2] <∞ for any θ ∈ Θ and a ∈ {0, 1}.
(3) There exists a unique zero, denoted as θ = (∆, βt)t, of
piE[ψ(1,X, Y (1),M(1); θ)] + (1− pi)E[ψ(0,X, Y (0),M(0); θ)] = 0.
(4) For each a ∈ {0, 1}, the function θ 7→ ψ(a, x, y,m; θ) is twice continuously dif-
ferentiable for every (x, y,m) in the support of (X, Y (a),M(a)) and is dominated by an
integrable function u(X, Y (a),M(a)).
(5) There exist a C > 0 and and integrable function v(X, Y (a),M(a)), such that
|| ∂2
∂θ∂θt
ψ(a, x, y,m; θ)|| < v(x, y,m) element-wise for every (a, x, y,m) in the support of
(A,X, Y (a),M(a)) and θ with ||θ − θ|| < C.
(6) E
[∣∣∣∣∣∣ ∂∂θψ(a,X, Y (a),M(a); θ)∣∣∣
θ=θ
∣∣∣∣∣∣2] <∞ for a = 0, 1 and
piE
[
∂
∂θ
ψ(1,X, Y (1),M(1); θ)
∣∣∣
θ=θ
]
+ (1− pi)E
[
∂
∂θ
ψ(0,X, Y (0),M(0); θ)
∣∣∣
θ=θ
]
is invertible.
The above regularity conditions can be equivalently expressed in terms of distribution
P ∗ instead of P (using the result of Lemma 3 in Section D). Specifically, conditions (2),
(3) and (6) are equivalent to conditions (2’), (3’) and (6’) below respectively:
(2’) E∗[||ψ(A,X, Y,M ; θ)||2] <∞ for any θ ∈ Θ.
(3’) There exists a unique zero, denoted as θ = (∆, βt)t, of E∗[ψ(A,X, Y,M ; θ)] = 0.
(6’) E∗
[∣∣∣∣∣∣ ∂∂θψ(A,X, Y,M ; θ)∣∣∣
θ=θ
∣∣∣∣∣∣2] < ∞ and E∗ [ ∂∂θψ(A,X, Y,M ; θ)∣∣∣
θ=θ
]
is in-
vertible.
2
B Consistent estimator of V in Theorem 1
We define
V̂ = V˜n − 1
pi(1− pi)
∑
s∈S
p̂(s)d̂(s)2,
where V˜n = e
t
1B̂
−1
ĈB̂
−1,t
e1, p̂(s) = n
−1∑n
i=1 I{Si = s} and
d̂(s) =
1
n
n∑
i=1
I{Si = s}
p̂(s)
et1B̂
−1
(Ai − pi)ψ(Ai,X i, Yi,Mi; θ̂),
where
B̂ =
1
n
n∑
i=1
∂
∂θ
ψ(Ai,Xi, Yi,Mi; θ)
∣∣∣∣
θ=θ̂
,
Ĉ =
1
n
n∑
i=1
ψ(Ai,Xi, Yi,Mi; θ̂)ψ(Ai,Xi, Yi,Mi; θ̂)
t,
I{Z} is an indicator function which equals 1 if Z is true and 0 otherwise, and e1 is a
(p+1)-dimensional column vector with the first entry 1 and the rest 0. If p̂(s˜) = 0 for some
s˜ ∈ S, which means there are no participants with Si = s˜, we let d(s˜) = 0 by convention.
Consistency of V̂ to V is shown in Section D.1.
C Expression of V (a)(t, t′) and consistent estimator of
V (a)(t, t) in Theorem 2
In the setting of survival analysis, we introduce the following notations in addition to those
already defined in Section 6 of the main paper.
Define the potential survival function S
(a)
0 (t) = P (Y (a) > t) for each a = 0, 1 and
t ∈ [0, τ ]. Let U(a) = min{Y (a),M(a)} and δ(a) = I{Y (a) ≤ M(a)} for each a ∈ {0, 1}.
3
Define N(t) = I{U ≤ t, δ = 1} and N (a)(t) = I{U(a) ≤ t, δ(a) = 1} for each a = 0, 1 and
t ∈ [0, τ ]. For each a = 0, 1 and t ∈ [0, τ ], we further define
H(a)(t) =
∫ t′=t
t′=0
dL(a)(t′)
(1−∆Λ(a)(t′))P (U(a) ≥ t′) , (1)
where
L(a)(t) = N (a)(t)−
∫ t′=t
t′=0
I{U(a) ≥ t′}dΛ(a)(t′),
Λ(a)(t) = E
[∫ t′=t
t′=0
dN (a)(t′)
P (U(a) ≥ t′)
]
,
∆Λ(a)(t) = Λ(a)(t)− Λ(a)(t−),
with Λ(a)(t−) representing the left limit of Λ(a)(t). Then IF (a)(A,U, δ; t) is defined as
IF (a)(A,U, δ; t) = −I{A = a}
pia
S
(a)
0 (t)H
(a)(t).
For t, t′ ∈ [0, τ ], we define
V (a)(t, t′) = S(a)0 (t)S
(a)
0 (t
′)
{
1
pia
E[Cov(H(a)(t), H(a)(t′)|S)]
+ Cov(E[H(a)(t)|S], E[H(a)(t′)|S])
}
, (2)
where pia = api + (1− a)(1− pi) for a ∈ {0, 1}. We estimate V (a)(t, t) by
V̂ (a)(t, t) =
Ŝ
(a)
n (t)2
pia
B̂(a)(t)− (1− pia)
pia
∑
s∈S
p̂(s)
(∑n
i=1 I{Si = s}Ĥ(a)i (t)∑n
i=1 I{Si = s}
)2 , (3)
where Ŝ
(a)
n (t) is the Kaplan-Meier estimator defined in Section 6 of the main paper,
B̂(a)(t) =
∫ t′=t
t′=0
dΛ̂(a)(t′)
P̂ (U(a) ≥ t′)(1−∆Λ̂(a)(t′))
,
Ĥ
(a)
i (t) =
∫ t′=t
t′=0
I{Ai = a}(dNi(t′)− I{Ui ≥ t′}dΛ̂(a)(t′))
piaP̂ (U(a) ≥ t′)(1−∆Λ̂(a)(t′))
,
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with
P̂ (U(a) ≥ t) =
∑n
i=1 I{Ai = a}I{Ui ≥ t}∑n
i=1 I{Ai = a}
,
Λ̂(a)(t) =
∫ t′=t
t′=0
∑n
i=1 I{Ai = a}dNi(t′)∑n
i=1 I{Ai = a}I{Ui ≥ t′}
,
∆Λ̂(a)(t) =
∑n
i=1 I{Ai = a}I{Ui = t, δi = 1}∑n
i=1 I{Ai = a}I{Ui ≥ t}
.
Consistency of V̂ (a)(t, t) to V (a)(t, t) is shown in Section D.3.
D Proofs of main results
D.1 Proof of Theorem 1
In this section, we first present three lemmas that are critical for proving our main results.
Lemmas 1 and 2 generalize results of Bugni et al. (2018) and the proofs of them are very
similar to Bugni et al. (2018). Lemmas 3 connects P , which involves unobserved potential
outcomes, and P ∗, the distribution of observed data. Then we prove Theorem 1 based on
these lemmas.
Lemma 1. Let Z(θ) = h(Y (1), Y (0),M(1),M(0),X; θ) for some function h and θ ∈
Θ. For each s ∈ S, let Zs(θ) denote the random variable Z(θ)|(S = s). Supposing
{Z1(θ), . . . , Zn(θ)} are independent samples from the distribution of Z(θ), then under strat-
ified randomization or the biased-coin design,
(1) if E[|Z(θ)|] <∞ for each θ ∈ Θ, then 1
n
∑n
i=1AiZi(θ)
P−→ piE[Z(θ)];
(2) if supθ∈Θ |E[Zs(θ)]| < ∞ and the class of functions {Z(s)(θ) : θ ∈ Θ} is P-Glivenko-
Cantelli for each s ∈ S, then sup
θ∈Θ
∣∣ 1
n
∑n
i=1AiZi(θ)− piE[Zi(θ)]
∣∣ P−→ 0 .
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Proof. For the first part of the Lemma, see Lemma B.3 in the supplementary mate-
rial of Bugni et al. (2018). The only difference is that we replace (Yi(1), Yi(0), Si) by
(Yi(1), Yi(0),Mi(1),Mi(0),X i) and all of the arguments still hold.
For the second part of the Lemma, we give the proof that generalizes the arguments
in Lemma B.3 in the supplementary material of Bugni et al. (2018) to the supremum over
a class of functions. Under stratified randomization or the biased-coin design, we have
(Z1(θ), . . . , Zn(θ))⊥⊥(A1, . . . , An)|(S1, . . . , Sn). Then, for each θ ∈ Θ, 1n
∑n
i=1AiZi(θ) has
the same distribution with the same quantity where Zi(θ) are ordered by strata and then
by treatment group (Ai = 1 first) within each stratum. Independently for each s ∈ S and
independently of (A1, . . . , An) and (S1, . . . , Sn), let {Zs1(θ), . . . , Zsn(θ)} be independent sam-
ples from the distribution Zs(θ). By construction, { 1
n
∑n
i=1AiZi(θ)|(A1, S1, . . . , An, Sn)}
has the same distribution with {∑s∈S 1n∑n1(s)i=1 Zsi (θ)|(A1, S1, . . . , An, Sn)} , where n1(s) =∑n
i=1AiI{Si = s}. Hence 1n
∑n
i=1AiZi(θ) has the same distribution with
∑
s∈S
1
n
∑n1(s)
i=1 Z
s
i (θ).
Then it suffices to show sup
θ∈Θ | 1n
∑n1(s)
i=1 Z
s
i (θ)− piP (S = s)E[Zs(θ)]| P−→ 0 for each s ∈ S.
Under stratified randomization or the biased-coin design, we have n1(s)
n
P−→ piP (S = s).
Since n1(s) does not involve θ, we have
sup
θ∈Θ
∣∣∣∣1n
n1(s)∑
i=1
Zsi (θ)− piP (S = s)E[Zs(θ)]
∣∣∣∣
=
n1(s)
n
sup
θ∈Θ
∣∣∣∣ 1n1(s)
n1(s)∑
i=1
Zsi (θ)−
npiP (S = s)
n1(s)
E[Zs(θ)]
∣∣∣∣
≤ n1(s)
n
sup
θ∈Θ
∣∣∣∣ 1n1(s)
n1(s)∑
i=1
Zsi (θ)− E[Zs(θ)]
∣∣∣∣+ n1(s)n supθ∈Θ
∣∣∣∣ (npiP (S = s)n1(s) − 1
)
E[Zs(θ)]
∣∣∣∣
= (piP (S = s) + op(1)) sup
θ∈Θ
∣∣∣∣ 1n1(s)
n1(s)∑
i=1
Zsi (θ)−E[Zs(θ)]
∣∣∣∣ + op(1) sup
θ∈Θ
|E[Zs(θ)]|.
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Since sup
θ∈Θ |E[Zs(θ)]| <∞, then it suffices to show supθ∈Θ | 1n1(s)
∑n1(s)
i=1 Z
s
i (θ)−E[Zs(θ)]| P−→
0. To this end, by the almost sure representation theorem, we can construct n˜1(s)
n
such that
n˜1(s)
n
has the same distribution with n1(s)
n
and n˜1(s)
n
→ piP (S = s) almost surely. Since
(A1, . . . , An) and (S1, . . . , Sn) are independent of {Zs1(θ), . . . , Zsn(θ)}, we have, for any
ε > 0
P
sup
θ∈Θ
∣∣∣∣ 1n1(s)
n1(s)∑
i=1
Z
s
i (θ)− E[Zs(θ)]
∣∣∣∣ > ε
 = P
sup
θ∈Θ
∣∣∣∣ 1
n
n1(s)
n
n
n1(s)
n∑
i=1
Z
s
i (θ)− E[Zs(θ)]
∣∣∣∣ > ε

= P
sup
θ∈Θ
∣∣∣∣ 1
n
n˜1(s)
n
n
n˜1(s)
n∑
i=1
Z
s
i (θ)− E[Zs(θ)]
∣∣∣∣ > ε

= E
P
sup
θ∈Θ
∣∣∣∣ 1
n
n˜1(s)
n
n
n˜1(s)
n∑
i=1
Z
s
i (θ)− E[Zs(θ)]
∣∣∣∣ > ε∣∣ n˜1(s)n

 .
Given the above derivation, if we can show
P
sup
θ∈Θ
∣∣∣∣ 1
n n˜1(s)
n
n
n˜1(s)
n∑
i=1
Zsi (θ)− E[Zs(θ)]
∣∣∣∣ > ε| n˜1(s)n
→ 0 almost surely, (4)
then the dominated convergence theorem implies the desired result. To see this, since the
class of functions {Z(s)(θ) : θ ∈ Θ} is P-Glivenko-Cantelli, then sup
θ∈Θ
∣∣ 1
nk
∑nk
i=1 Z
s
i (θ)−
E[Zs(θ)]
∣∣ P−→ 0 for any nk → ∞ as k → ∞. Then (4) follows from the almost sure
convergence of n n˜1(s)
n
to infinity and the independence of n˜1(s)
n
and {Zs1(θ), . . . , Zsn(θ)}.
Lemma 2. Given Assumption 1, let Zi(1) = h1(Yi(1),Mi(1),X i) and
Zi(0) = h2(Yi(0),Mi(0),Xi) for some functions h1 and h2 such that E[Zi(a)
2] < ∞ for
a = 0, 1. Then under stratified randomization or the biased-coin design,
1√
n
n∑
i=1
{
Ai
pi
(Zi(1)− E[Zi(1)])− 1− Ai
1− pi (Zi(0)− E[Zi(0)])
}
d−→ N(0, σ21 + σ22),
7
where
σ21 =
1
pi
V ar(Z(1)−E[Z(1)|S]) + 1
1− piV ar(Z(0)− E[Z(0)|S]),
σ22 = V ar(E[Z(1)− Z(0)|S]).
Proof. See Lemma B.1 and Lemma B.2 in the supplementary material of Bugni et al.
(2018). The only difference is that we replace Yi(a) by Zi(a) and all of the arguments
still hold.
Lemma 3. Let f(X, Y (a)M(a),M(a)) be a function with E[f(X, Y (a)M(a),M(a))2] <∞
for a = 0, 1. Then
E∗[I{A = a}f(X, Y M,M)] = piaE[f(X, Y (a)M(a),M(a))],
E∗[I{A = a}f(X, Y M,M)|S] = piaE[f(X, Y (a)M(a),M(a))|S],
where pia = pia+ (1− pi)(1− a).
Proof. We first prove the second equation. The definition of P ∗ implies that, for a =
0, 1 and s ∈ S, f(X, Y M,M)|(A = a, S = s) is equal to f(X, Y (a)M(a),M(a))|(A =
a, S = s). Since A is independent of (X, Y (a)M(a),M(a)) and S is encoded as dummy
variables in X, then A is independent of S and f(X, Y (a)M(a),M(a)), which implies
f(X, Y (a)M(a),M(a))|(A = a, S = s) and f(X, Y (a)M(a),M(a))|(S = s) are identically
distributed. Hence E∗[f(X, Y M,M)|A = a, S = s] = E[f(X, Y (a)M(a),M(a))|S = s].
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Then the second equation is proved by the following derivation:
E[f(X, Y (a)M(a),M(a))|S = s]
= E∗[f(X, Y M,M)|A = a, S = s]
=
1
P (A = a, S = s)
E∗[I{A = a}I{S = s}f(X, Y M,M)]
=
1
P (A = a)P (S = s)
E∗[I{A = a}I{S = s}f(X, Y M,M)]
=
1
P (A = a)
E∗[I{A = a}f(X, Y M,M)|S = s].
The first equation is followed because
E∗[I{A = a}f(X, Y M,M)]
=
∑
s∈S
E[I{A = a}I{S = s}f(X, Y (a)M(a),M(a))]
=
∑
s∈S
E∗[f(X, Y M,M)|A = a, S = s]P (A = a, S = s)
=
∑
s∈S
E[f(X, Y (a)M(a),M(a))|S = s]P (A = a)P (S = s)
= P (A = a)E[f(X, Y (a)M(a),M(a))].
Proof of Theorem 1. Under simple randomization, the results of Theorem 1 have been
proved in Section 5 of van der Vaart (1998). Hence, it remains to prove Theorem 1 under
stratified randomization and the biased-coin design,which we do below. To simplify the no-
tation, we define ψ(a)(θ) = ψ(a,X, Y (a),M(a); θ) and ψ
(a)
i (θ) = ψ(a,X i, Yi(a),Mi(a); θ)
for a = 0, 1 and i = 1, . . . , n.
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Using the fact that Yi = Yi(1)Ai + Yi(0)(1 − Ai) and Mi = Mi(1)Ai +Mi(0)(1 − Ai),
the estimating equations (1) from the main paper can be re-written as
1
n
n∑
i=1
ψ(Ai,X i, Yi,Mi; θ) =
1
n
n∑
i=1
{Aiψ(1)i (θ) + (1−Ai)ψ(0)i (θ)} = 0.
We first show that θ̂
P−→ θ, where θ is the vector that solves
piE[ψ(1)(θ)] + (1− pi)E[ψ(0)(θ)] = 0.
Regularity condition (3) implies that θ exists and is unique. For each a ∈ {0, 1} and
s ∈ S, let ψ(a,s)(θ) denote the random variable ψ(a)(θ)|(S = s), i.e., ψ(a)(θ) conditional on
S = s. Equivalently, ψ(a,s)(θ) = ψ(a,X|(S = s), Y (a)|(S = s),M(a)|(S = s); θ) and we
have ψ(a)(θ) =
∑
s∈S I{S = s}ψ(a,s)(θ). Since (X|(S = s), Y (a)|(S = s),M(a)|(S = s))
lies in the support of (X, Y (a),M(a)), then regularity condition (4) implies that the map
θ 7→ ψ(a,s)(θ) is continuous in its support and dominated by an integrable function. Ex-
ample 19.8 of van der Vaart (1998) implies that the class of functions {ψ(a,s)(θ) : θ ∈ Θ}
is Glivenko-Cantelli. We also have supθ∈Θ |E[ψ(a,s)(θ)]| < ∞ since ψ(a,s)(θ) is domi-
nated by an integrable function. Then Lemma 1 implies that sup
θ∈Θ | 1n
∑n
i=1Aiψ
(a)
i (θ)−
piE[ψ(a)(θ)]| P−→ 0 and supθ∈Θ | 1n
∑n
i=1(1− Ai)ψ(a)i (θ)− (1− pi)E[ψ(a)(θ)]|
P−→ 0. Hence
sup
θ∈Θ
∣∣∣∣ 1n
n∑
i=1
{Aiψ(1)i (θ) + (1−Ai)ψ(0)i (θ)} − {piE[ψ(1)(θ)] + (1− pi)E[ψ(0)(θ)]}
∣∣∣∣
≤ sup
θ∈Θ
∣∣∣∣ 1n
n∑
i=1
Aiψ
(a)
i (θ)− piE[ψ(a)(θ)]
∣∣∣∣+ sup
θ∈Θ
∣∣∣∣ 1n
n∑
i=1
(1− Ai)ψ(a)i (θ)− (1− pi)E[ψ(a)(θ)]
∣∣∣∣
P−→ 0.
Since Θ is unique and 1
n
∑n
i=1{Aiψ(1)i (θ̂)+(1−Ai)ψ(0)i (θ̂)} = 0, Theorem 5.9 of van der Vaart
(1998) implies that θ̂
P−→ θ.
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We then show θ̂ is asymptotically linear by an argument that follows the general ap-
proach. By multivariate Taylor expansion of function
∑n
i=1
{
Aiψ
(1)
i (θ̂) + (1−Ai)ψ(0)i (θ̂)
}
around the point θ = θ, we have
0 =
1
n
n∑
i=1
{
Aiψ
(1)
i (θ̂) + (1− Ai)ψ(0)i (θ̂)
}
=
1
n
n∑
i=1
{
Aiψ
(1)
i (θ) + (1− Ai)ψ(0)i (θ)
}
+
1
n
n∑
i=1
{
Aiψ˙
(1)
i (θ) + (1−Ai)ψ˙
(0)
i (θ)
}
(θ̂ − θ)
+
1
2
(θ̂ − θ)t 1
n
n∑
i=1
{
Aiψ¨
(1)
i (θ˜) + (1− Ai)ψ¨
(0)
i (θ˜)
}
(θ̂ − θ),
where ψ˙
(a)
i (θ) =
∂
∂θ
ψ
(a)
i (θ)
∣∣
θ=θ
, ψ¨
(a)
i (θ˜) =
∂2
∂θ∂θt
ψ
(a)
i (θ)
∣∣
θ=θ˜
for a = 0, 1 and θ˜ is a random
point on the line segment between θ̂ and θ.
According to regularity condition (5), there exists a ball K around θ such that
ψ¨
(a)
i (θ) is dominated by a function v(X i, Yi(a),Mi(a)). Hence, if θ˜ ∈ K, then∣∣∣∣∣∣ 1
n
n∑
i=1
{
Aiψ¨
(1)
i (θ˜) + (1− Ai)ψ¨
(0)
i (θ˜)
} ∣∣∣∣∣∣ ≤ ∑
a∈{0,1}
1
n
n∑
i=1
||v(Xi, Yi(a),Mi(a))||,
which is bounded in probability by the law of large numbers. Furthermore, since P (θ˜ ∈
K) → 1, we then have 1
n
∑n
i=1
{
Aiψ¨
(1)
i (θ˜) + (1− Ai)ψ¨
(0)
i (θ˜)
}
= Op(1). Recalling that
B = E∗[ ∂
∂θ
ψ(A,X, Y,M ; θ)
∣∣
θ=θ
] = piE[ψ˙
(1)
(θ)] + (1 − pi)E[ψ˙(0)(θ)], by Lemma 1 and
regularity condition (6), we have
1
n
n∑
i=1
{
Aiψ˙
(1)
i (θ) + (1−Ai)ψ˙
(0)
i (θ)
}
P−→ B.
Combination of above facts implies that
1
n
n∑
i=1
{
Aiψ
(1)
i (θ) + (1− Ai)ψ(0)i (θ)
}
= −(B + op(1))(θ̂− θ)− (θ̂− θ)tOp(1)(θ̂− θ). (5)
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Given equation (5), we also need
√
n(θ̂− θ) = Op(1) to prove the asymptotic linearity. To
see this, we derive
1√
n
n∑
i=1
{
Aiψ
(1)
i (θ) + (1−Ai)ψ(0)i (θ)
}
=
1√
n
n∑
i=1
[
Ai{ψ(1)i (θ)− E[ψ(1)(θ)]}+ (1−Ai){ψ(0)i (θ)− E[ψ(0)(θ)]}
]
+
1√
n
n∑
i=1
{AiE[ψ(1)(θ)] + (1−Ai)E[ψ(0)(θ)]}
=
1√
n
n∑
i=1
[
Ai{ψ(1)i (θ)− E[ψ(1)(θ)]}+ (1−Ai){ψ(0)i (θ)− E[ψ(0)(θ)]}
]
+
1√
n
n∑
i=1
(Ai − pi)E[ψ(1)(θ)−ψ(0)(θ)]
=
1√
n
n∑
i=1
[
Ai{ψ(1)i (θ)− E[ψ(1)(θ)]}+ (1−Ai){ψ(0)i (θ)− E[ψ(0)(θ)]}
]
+ op(1), (6)
where the second last equation comes from the fact that E[piψ(1)(θ) + (1− pi)ψ(0)(θ)] = 0
and the last equation results from stratified randomization or the biased coin design, which
implies 1√
n
∑n
i=1(Ai − pi)
P−→ 0. Letting Zi(1) = piψ(1)i (θ) and Zi(0) = −(1− pi)ψ(0)i (θ), by
applying Lemma 2, we have 1√
n
∑n
i=1
{
Aiψ
(1)
i (θ) + (1− Ai)ψ(0)i (θ)
}
= Op(1). Multiplying
√
n on both sides of equation (5) and using θ̂ − θ = op(1), we get
Op(1) = −B
√
n(θ̂ − θ) + op(
√
n(θ̂ − θ)).
Since B is invertible (regularity condition 6), we get
√
n(θ̂ − θ) = Op(1). Then from
equation (5), we get
√
n(θ̂ − θ) = −B−1 1√
n
n∑
i=1
ψ(Ai,X i, Yi,Mi; θ) + op(1), (7)
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this completes the proof of asymptotic linearity.
We next show θ̂ is asymptotically normal using Lemma 2. Combining expressions (6)
and (7), we have
√
n(θ̂−θ) = −B−1 1√
n
n∑
i=1
[
Ai{ψ(1)i (θ)− E[ψ(1)(θ)]}+ (1− Ai){ψ(0)i (θ)−E[ψ(0)(θ)]}
]
+op(1).
Letting Zi(1),Zi(0) be the first entry of−piB−1ψ(1)i (θ) and (1−pi)B−1ψ(0)i (θ) respectively,
we apply Lemma 2 to the first entry of
√
n(θ̂− θ) and get √n(∆̂−∆) d−→ N(0, V ∗), where
V ∗ is the first-row, first-column entry of B−1DB−1,t with
D = piE[V ar{ψ(1)(θ)|S}] + (1− pi)E[V ar{ψ(0)(θ)|S}]
+ E
[
E[piψ(1)(θ) + (1− pi)ψ(0)(θ)|S]E[piψ(1)(θ) + (1− pi)ψ(0)(θ)|S]t
]
,
where V ar represents the variance-covariate matrix.
To show that V = V ∗, we use the result by Theorem 5.21 of van der Vaart (1998) that
V˜ is the first-row first-column entry of B−1CB−1,t, where, by Lemma 3,
C = E∗[ψ(A,X, Y,M ; θ)ψ(A,X, Y,M ; θ)t]
= piE[ψ(1)(θ)ψ(1)(θ)t] + (1− pi)E[ψ(0)(θ)ψ(0)(θ)t].
Then it suffices to show that the first-row first-column entry of B−1(C − D)B−1,t is
1
pi(1−pi)E
∗ [E∗[(A− pi)IF (A,X, Y,M)|S]2], where IF (A,X, Y,M) is the first entry of
13
−B−1ψ(A,X, Y,M ; θ). We have the following derivation:
C −D = piE[ψ(1)(θ)ψ(1)(θ)t] + (1− pi)E[ψ(0)(θ)ψ(0)(θ)t]
− pi
(
E[ψ(1)(θ)ψ(1)(θ)t]−E
[
E[ψ(1)(θ)|S]E[ψ(1)(θ)|S]t
])
− (1− pi)
(
E[ψ(0)(θ)ψ(0)(θ)t]−E
[
E[ψ(0)(θ)|S]E[ψ(0)(θ)|S]t
])
− E
[
E[piψ(1)(θ) + (1− pi)ψ(0)(θ)|S]E[piψ(1)(θ) + (1− pi)ψ(0)(θ)|S]t
]
= piE
[
E[ψ(1)(θ)|S]E[ψ(1)(θ)|S]t
]
+ (1− pi)E
[
E[ψ(0)(θ)|S]E[ψ(0)(θ)|S]t
]
− E
[
E[piψ(1)(θ) + (1− pi)ψ(0)(θ)|S]E[piψ(1)(θ) + (1− pi)ψ(0)(θ)|S]t
]
= pi(1− pi)E
[
E[ψ(1)(θ)−ψ(0)(θ)|S]E[ψ(1)(θ)−ψ(0)(θ)|S]t
]
=
1
pi(1− pi)E
∗ [E∗[(A− pi)ψ(A,X, Y,M ; θ)|S]E∗[(A− pi)ψ(A,X, Y,M ; θ)|S]t] .
The last equation uses Lemma 3, which implies that E∗[(A − pi)ψ(A,X, Y,M ; θ)|S] =
E[ψ(1)(θ) − ψ(0)(θ)|S] and E[f(S)] = E∗[f(S)] for any f(S) with finite second mo-
ment. Then using the definition of IF (A,X, Y,M), the first-row first-column entry of
B−1(C −D)B−1,t is 1
pi(1−pi)E
∗ [E∗[(A− pi)IF (A,X, Y,M)|S]2]. This completes the proof
of asymptotic normality with the desired asymptotic variance.
To prove that V can be consistently estimated by V̂ defined in Section B, we first show
B̂
P−→ B. By multivariate Taylor’s expansion of 1
npi
∑n
i=1Aiψ˙
(1)
i (θ̂) around the point θ = θ,
we have
1
npi
n∑
i=1
Aiψ˙
(1)
i (θ̂)−
1
npi
n∑
i=1
Aiψ˙
(1)
i (θ) =
1
npi
n∑
i=1
Aiψ¨
(1)
i (θ˜)(θ̂ − θ),
where θ˜ is a random point on the line segment between θ̂ and θ. Regularity condition (5)
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indicates that 1
n
∑n
i=1Aiψ¨
(1)
i (θ˜) = Op(1) since θ̂
P−→ θ. As a result, by Lemma 1,
1
npi
n∑
i=1
Aiψ˙
(1)
i (θ̂) =
1
npi
n∑
i=1
Aiψ˙
(1)
i (θ) + op(1) = E
[
ψ˙
(1)
(θ)
]
+ op(1).
Similarly, we have
∑n
i=1
1−Ai
n(1−pi)ψ˙
(0)
i (θ̂) = E
[
ψ˙
(0)
(θ)
]
+ op(1). Hence
B̂ =
1
n
n∑
i=1
∂
∂θ
ψ(Ai,X i, Yi,Mi; θ)
∣∣∣∣
θ=θ̂
=
1
n
n∑
i=1
Aiψ˙
(1)
i (θ̂) +
1
n
n∑
i=1
(1−Ai)ψ˙(0)i (θ̂)
= piE
[
ψ˙
(1)
(θ)
]
+ (1− pi)E
[
ψ˙
(0)
(θ)
]
+ op(1)
= B + op(1).
Following a similar proof, Lemma 1 implies Ĉ
P−→ C and d̂(s) P−→ E∗[(A−pi)ψ(Ai,X i, Yi,Mi)|S =
s] for each s ∈ S. By continuous mapping theorem, we get V̂ P−→ V .
D.2 Proof of Corollary 1
Proof. Since the ANCOVA estimator and standardized logistic regression estimator are
special cases of the DR-WLS estimator, we only present the proof for the DR-WLS esti-
mator. Given Assumption 1 and regularity conditions in Section A, Theorem 1 shows that
∆̂DR−WLS is consistent to ∆ and asymptotically normal.
We first show that ∆̂DR−WLS is doubly robust. Denote h(A,X) = g−1(β0+βAA+β
t
X
X)
and e(A,X) = expit(α0 + αAA + α
t
X
X). If we assume that the model for missingness is
correctly specified, then E[M(a)|X ] = e(a,X) for a = 0, 1. Using the missing at random
assumption and the positivity assumption, we have
0 = E[M(a)Y (a)−h(a,X)
e(a,X)
] = E
[
E[M(a)|X ]E[Y (a)|X ]−h(a,X)
e(a,X)
]
= E[Y (a)]− E[h(a,X)].
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This implies that E[Y (a)] = E[h(a,X)] for each a = 0, 1; this claim also holds if, instead
of assuming that the model for missingness is correctly specified, we assume that h(A,X)
is correctly specified, then E[Y (a)|X] = h(a,X) and hence E[Y (a)] = E[E[Y (a)|X]] =
E[h(a,X)] for a = 0, 1. As a result, if at least one of the two working models is correctly
specified, then ∆ = E[h(1,X)] − E[h(0,X)] = ∆∗. This proves double robustness of the
DR-WLS estimator.
We next calculate V˜ − V . Derived from Theorem 5.21 of van der Vaart (1998), the
influence function of the DR-WLS estimator is
IF (A,X, Y,M) =
(
A− pi
pi(1− pi) − c1Z
)
M{Y − h(A,X)}
e(A,X)
− c2Z{M − e(A,X)}
+ h(1,X)− h(0,X)−∆,
where Z = (1, A,Xt)t,
c1 = E
∗
[
A− pi
pi(1− pi)
(
M
e(A,X)
− 1
)
hβ(A,X)
]t{
E∗
[
M
e(A,X)
hβ(A,X)Z
t
]}−1
,
c2 = E[hβ(1,X)− hβ(0,X)]t
{
E∗
[
M
e(A,X)
hβ(A,X)Z
t
]}−1
E∗
[
Meα(A,X)
e(A,X)2
{Y − h(A,X)}Zt
]
{E∗[eα(A,X)Zt]}−1,
with hβ(A,X) =
∂
∂β
g(β0+ βAA+β
t
X
X)
∣∣
β=β
, eα(A,X) =
∂
∂α
expit(α0+αAA+α
t
X
X)
∣∣
α=α
.
Applying Theorem 1, we get V˜ − V = 1
pi(1−pi)E
∗ [E∗[(A− pi)IF (A,X, Y,M)|S]2]. To
calculate this quantity, we observe that, if the outcome regression model is correctly spec-
ified, then c2 = 0 and E
∗[(A − pi)M Y−h(A,X)
e(A,X)
Z|S] = 0; if the missing model is correctly
specified, then c1 = 0 and E
∗[(A − pi){M − e(A,X)}Z|S] = 0. Furthermore, Lemma 3
implies that E∗[(A− pi){h(1,X)− h(0,X)−∆}|S] = 0. Hence, if at least one of the two
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models is correct, then
E∗[(A− pi)IF (A,X, Y,M)|S] = E∗
[
(A− pi)2
pi(1 − pi)
M{Y − h(A,X)}
e(A,X)
∣∣∣∣S] .
Since S is a categorical variable and adjusted in the outcome regression model, then the defi-
nition of θ (i.e., the solution toE∗[ψ(A,X, Y,M ; θ)] = 0) implies that E∗
[
M{Y−h(A,X)}
e(A,X)
∣∣S] =
0. Therefore
V˜ − V = (1− 2pi)
2
pi3(1− pi)3E
∗
[
E∗
[
AM{Y − h(A,X)}
e(A,X)
∣∣∣∣S]2
]
.
When pi = 0.5, it is straightforward that V˜ = V . If the outcome regression model includes
treatment-by-randomization-strata interaction terms, then according to the definition of
θ, E∗
[
AM{Y−h(A,X)}
e(A,X)
I{S = s}
]
= 0 for each s ∈ S, we have E∗
[
AM{Y−h(A,X)}
e(A,X)
∣∣S] = 0 and
hence V˜ = V . If the outcome regression model is correctly specified, then E[Y (1)|X] =
h(1,X). Together with the missing at random assumption, we have E
[
M(1){Y (1)−h(1,X)}
e(1,X)
∣∣X] =
E
[
E[M(1)|X]{E[Y (1)|X]−h(1,X)}
e(1,X)
∣∣X] = 0. By Lemma 3, we have E∗ [AM{Y−h(A,X)}
e(A,X)
∣∣S] =
piE
[
M(1){Y (1)−h(1,X)}
e(1,X)
∣∣S] = 0, which implies V˜ = V .
D.3 Proof of Theorem 2
In this section, we first present Lemma 4, which gives a central limit theorem for dependent
stochastic processes under stratified randomization or the biased-coin design. We then
present Lemma 5, which gives detailed algebra for a decomposition used in the proof of
Lemma 4. Given Lemma 4, we prove Theorem 2.
Lemma 4. Let S be a random variable taking values in a discrete set S = {1, . . . , k}.
Let {R(t) : t ∈ [0, τ ]} be a real-valued, uniformly bounded (i.e. P (supt |R(t)| < M) = 1
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for some constant M > 0) stochastic process such that the conditional process {R(t)|(S =
s) : t ∈ [0, τ ]} is P-Donsker for each s ∈ S. Let (Si, Ri), i = 1, . . . , n be independent
samples from the joint distribution of (S,R). Let (A1, . . . , An) be a vector of binary random
variables such that (1) (R1, . . . , Rn)⊥⊥(A1, . . . , An)|(S1, . . . , Sn) and (2) n−1/2
∑n
i=1(Ai −
pi)I{Si = s}|(S1, . . . , Sn) P−→ 0 a.s. for every s ∈ S and some constant pi ∈ (0, 1). Then
1√
n
∑n
i=1
(
Ai
pi
Ri(t)−E[R(t)]
)
weakly converges to a tight, mean 0 Gaussian process with
covariance function
V (a)(t, t′) =
1
pi
E[Cov(R(t), R(t′)|S)] + Cov(E[R(t)|S], E[R(t′)|S]).
Proof. Consider the following derivation, which uses the same technique as Lemma B.1 of
the supplementary material of Bugni et al. (2018) with generalization to stochastic pro-
cesses:
1√
n
n∑
i=1
(
Ai
pi
Ri(t)− E[R(t)]
)
= Un,1(t) + Un,2(t) + Un,3(t),
where
Un,1(t) =
1√
n
n∑
i=1
Ai
pi
(Ri(t)− E[R(t)|Si]) ,
Un,2(t) =
∑
s∈S
√
n(
n(s)
n
− p(s))(E[R(t)|S = s]− E[R(t)]),
Un,3(t) =
∑
s∈S
Dn(s)
pi
√
n
E[R(t)|S = s],
with Dn(s) =
∑n
i=1(Ai − pi)I{Si = s}, n(s) =
∑n
i=1 I{Si = s} and p(s) = P (S = s). We
prove the above derivation in Lemma 5. In the rest of the proof, we use Un,1, Un,2, Un,3 to
represent the processes {Un,1(t) : t ∈ [0, τ ]}, {Un,2(t) : t ∈ [0, τ ]} and {Un,3(t) : t ∈ [0, τ ]}
respectively.
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We first show that Un,3(t)
d−→ 0 uniformly in t. Since the definition of (A1, . . . , An)
implies that Dn(s)√
n
d−→ 0, then for any ε > 0,
P ∗
(
sup
t
|Un,3(t)| > ε
)
≤ P ∗
(∑
s∈S
sup
t
∣∣∣∣E[R(t)|S = s]∣∣∣∣∣∣∣∣Dn(s)pi√n
∣∣∣∣ > ε
)
,
where P ∗ represents outer probability measure (Section 6.2 of Kosorok, 2008). Since R(t)
is uniformly bounded, we can bound supt
∣∣E[R(t)|S = s]∣∣ by a constant for all s ∈ S. Then
we get limn→∞ P ∗ (supt |Un,3(t)| > ε) = 0.
We next show that the process Un,2 weakly converges to a tight, mean 0 Gaussian
process with covariance function V2(t, t
′) = Cov(E[R(t)|S], E[R(t′)|S]). For each s ∈ S,
since {I{S = s} : t ∈ [0, τ ]} is P-Donsker and E[R(t)|S = s] − E[R(t)] is uniformly
bounded, then {∑s∈S I{S = s}(E[R(t)|S = s] − E[R(t)]) : t ∈ [0, τ ]} is P-Donsker by
Corollary 9.32 (i) and (v) of Kosorok (2008). Hence Un,2 weakly converges to a tight, mean
0 Gaussian process. The covariance function can be derived accordingly.
We next construct a process U∗n,1 such that U
∗
n,1 is independent of (Un,2, Un,3) and U
∗
n,1
weakly converges to a tight, mean 0 Gaussian process with covariance function
V1(t, t
′) =
1
pi
E[Cov(R(t), R(t′)|S)].
We then show in the next paragraph that Un,1(t)
d
= U∗n,1(t) + op∗(1), where
d
= means
random variables on both sides have the same distribution and op∗(1) represents a sequence
of processes {X(t) : t ∈ [0, τ ]} such that limn→∞ P ∗(supt∈[0,τ ] |Xn(t)| > ε) = 0 for any
ε > 0. To this end, independently for each s ∈ S and independently of (A1, . . . , An) and
(S1, . . . , Sn), let {Rsi (t) : t ∈ [0, τ ]}, i = 1 . . . , n be independent and identically distributed
processes with marginal distribution equal to the distribution of {R(t)|(S = s) : t ∈ [0, τ ]}.
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We define
U∗n,1(t) =
∑
s∈S
 1
pi
√
n
⌊n(F (s)+pip(s))⌋∑
i=⌊nF (s)⌋+1
{Rsi (t)− E[Rsi (t)]}
 ,
where F (s) = P (Si ≤ s). Since U∗n,1(t) is a function of Rsi (t), then U∗n,1(t) is independent of
(A1, S1, . . . , An, Sn). Using the fact that Un,2(t), Un,3(t) are functions of (A1, S1, . . . , An, Sn),
we conclude that U∗n,1 is independent of (Un,2, Un,3). For x ∈ R, let ⌊x⌋ be the largest
integer smaller than or equal to x. Since {R(t)|(S = s) : t ∈ [0, τ ]} is P-Donsker and
Rsi (t), i ∈ ⌊nF (s)⌋+1, . . . , ⌊n(F (s)+pip(s))⌋ are i.i.d with ⌊npip(s)⌋ (or ⌊npip(s)⌋+1) units
for each s ∈ S, we have 1
pi
√
n
∑⌊n(F (s)+pip(s))⌋
i=⌊nF (s)⌋+1 {Rsi (t)−E[Rsi (t)]} converges weakly to a tight
Gaussian process with covariance function p(s)
pi
Cov(R(t), R(t′)|S = s). Since the data from
different strata are independent, we get the desired convergence of U∗n,1(t).
We next show Un,1(t)
d
= U∗n,1(t) + op∗(1). Given the definition of (A1, . . . , An), Un,1(t)
has the same distribution of the same quantity where data are ordered by strata and then
by treatment group (Ai = 1 first) within each stratum. Define
U˜n,1(t) =
∑
s∈S
 1
pi
√
n
N(s)+n1(s)∑
i=N(s)+1
{Rsi (t)− E[Rsi (t)]}
 ,
where N(s) =
∑n
i=1 I{Si ≤ s} and n1(s) =
∑n
i=1 I{Si ≤ s, Ai = 1}. By the defini-
tion of Rsi (t), we have {Un,1(t)|A1, S1, . . . , An, Sn} d= {U˜n,1(t)|A1, S1, . . . , An, Sn} and hence
Un,1(t)
d
= U˜n,1(t). It suffices to prove that U˜n,1(t) = U
∗
n,1(t) + op∗(1), that is, for each fixed
s ∈ S,
∆n,s(t) =
1√
n
N(s)+n1(s)∑
i=N(s)+1
−
⌊n(F (s)+pip(s))⌋∑
i=⌊nF (s)⌋+1
 {Rsi (t)−E[Rsi (t)]}
converges in distribution to 0 uniformly. To this end, we observe that |∆n,s(t)| ≤ ∆˜n,s(t),
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where
∆˜n,s(t) =
1√
n
∣∣∣∣ max{N(s),⌊nF (s)⌋}∑
min{N(s),⌊nF (s)⌋}+1
{Rsi (t)−E[Rsi (t)]}
∣∣∣∣
+
1√
n
∣∣∣∣ max{N(s)+n1(s),⌊nF (s)+npip(s)⌋}∑
min{N(s)+n1(s),⌊nF (s)+npip(s)⌋}+1
{Rsi (t)−E[Rsi (t)]}
∣∣∣∣.
Define M(s) = |N(s) − ⌊nF (s)⌋|, and Gsn = { 1√n
∑n
i=1{R˜si (t) − E[R˜si (t)]} : t ∈ [0, τ ]},
where (R˜s1, . . . , R˜
s
n) are independent samples from process R|(S = s) and are independent
of (Rs1, . . . , R
s
n). We also define L(s) = |N(s) + n1(s) − ⌊n(F (s) + pip(s))⌋| and G˜sn to be
identically distributed as Gsn and independent of G
s
n and (R
s
1, . . . , R
s
n). Then ∆˜n,s(t)
d
=√
M(s)
n
|GsM(s)(t)|+
√
L(s)
n
|G˜sL(s)(t)|. For any ε > 0, since
P ∗(sup
t
|∆n,s(t)| > ε) ≤ P ∗(sup
t
∆˜n,s(t) > ε)
≤ P ∗
(√
M(s)
n
|GsM(s)(t)| >
ε
2
)
+ P ∗
(√
L(s)
n
|GsL(s)(t)| >
ε
2
)
,
it suffices to show
√
M(s)
n
GsM(s)(t) = op∗(1) and
√
L(s)
n
GsL(s)(t) = op∗(1). The central limit
theorem implies (N(s) − nF (s))/√n d−→ N(0, F (s)(1 − F (s)). Hence for any δ > 0, there
exist C0, C1 > 0 such that P (
√
nC0 ≤ M(s) ≤
√
nC1) ≥ 1 − δ for n large enough. Since
{R(t)|(S = s) : t ∈ [0, τ ]} is P-Donsker, then Gsn weakly converges to a tight Gaussian
process Gs. By the continuous mapping theorem (Theorem 7.7 of Kosorok, 2008), we have
supt |Gn(t)| converges weakly to supt |Gs(t)|, which implies that, for any δ > 0, there exists
a C > 0 such that P ∗ (supt |Gsn(t)| > C) < δ for n large enough. Since M(s) is independent
of R˜si and M(s) takes values on a finite set for fixed n, by Fubini’s Theorem (Lemma 1.2.7
of Vaart and Wellner, 1996) and the definition of iterative outer expectations (Page 10-11
of Vaart and Wellner, 1996), we have for any m ≥ 0 that P ∗(supt |
√
m
n
Gsm(t)| > ε,M(s) =
21
m) = P ∗(supt |
√
m
n
Gsm(t)| > ε)P (M(s) = m). Then for any ε, δ > 0 and n large enough,
we have the following derivation:
P ∗
(
sup
t
|
√
M(s)
n
GsM(s)(t)| > ε
)
≤ P ∗
(
sup
t
|
√
M(s)
n
GsM(s)(t)| > ε,M(s) ∈ [
√
nC0,
√
nC1]
)
+ P ∗
(
sup
t
|
√
M(s)
n
GsM(s)(t)| > ε,M(s) /∈ [
√
nC0,
√
nC1]
)
≤
∑
m∈[√nC0,
√
nC1]
P ∗
(
sup
t
|
√
m
n
Gsm(t)| > ε
)
P (M(s) = m) + P (M(s) /∈ [√nC0,
√
nC1])
<
∑
m∈[√nC0,
√
nC1]
P ∗
(
sup
t
|Gsm(t)| > n
1
4
ε
C1
)
P (M(s) = m) + δ
<
∑
m∈[√nC0,
√
nC1]
δP (M(s) = m) + δ
≤ 2δ.
Using the same technique, we have, for n large enough, P ∗(supt |
√
L(s)
n
G˜L(s)| > ε) ≤ 2δ,
which completes the proof of Un,1(t)
d
= U∗n,1(t) + op∗(1).
We next show (Un,1, Un,2, Un,3)
d
= (U∗n,1, Un,2, Un,3) + op∗(1). Since we have shown that
{Un,1(t)|A1, S1, . . . , An, Sn} d= {U˜n,1(t)|A1, S1, . . . , An, Sn} and Un,2(t), Un,3(t) are functions
of {A1, S1, . . . , An, Sn}, then (Un,1, Un,2, Un,3) d= (U˜n,1, Un,2, Un,3). Then it suffices to show
that (U˜n,1, Un,2, Un,3)
d
= (U∗n,1, Un,2, Un,3)+op∗(1). This is implied by the following derivation:
P ∗(sup
t
||(U˜n,1, Un,2, Un,3)− (U∗n,1, Un,2, Un,3)|| > ε) = P ∗(sup
t
|U˜n,1 − U∗n,1| > ε)→ 0,
where || · || represents the Euclidean norm.
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Finally, using the fact that U∗n,1⊥⊥Un,2, we have
1√
n
n∑
i=1
(
Ai
pi
Ri(t)−E[R(t)]
)
= Un,1(t) + Un,2(t) + Un,3(t)
d
= U∗n,1(t) + Un,2(t) + op∗(1)
weakly converges to the desired Gaussian process.
Lemma 5. Consider the same setting as Lemma 4. Then
1√
n
n∑
i=1
(
Ai
pi
Ri(t)− E[R(t)]
)
= Un,1(t) + Un,2(t) + Un,3(t),
where
Un,1(t) =
1√
n
n∑
i=1
Ai
pi
(Ri(t)− E[R(t)|Si]) ,
Un,2(t) =
∑
s∈S
√
n(
n(s)
n
− p(s))(E[R(t)|S = s]− E[R(t)]),
Un,3(t) =
∑
s∈S
Dn(s)
pi
√
n
E[R(t)|S = s],
with Dn(s) =
∑n
i=1(Ai − pi)I{Si = s}, n(s) =
∑n
i=1 I{Si = s} and p(s) = P (S = s).
Proof. Using the fact that E[R(t)|Si] =
∑
s∈S I{Si = s}E[R(t)|S = s], we have
Un,3(t) =
∑
s∈S
Dn(s)
pi
√
n
E[R(t)|S = s] = 1√
n
n∑
i=1
(
Ai
pi
− 1)E[R(t)|Si].
Using the fact that
∑
s∈S
∑n
i=1 I{Si = s} = n,
∑
s∈S p(s) = 1 andE[R(t)] = p(s)E[R(t)|S =
23
s], we have
Un,2(t) =
∑
s∈S
√
n(
n(s)
n
− p(s))(E[R(t)|S = s]−E[R(t)])
=
∑
s∈S
n(s)√
n
(E[R(t)|S = s]− E[R(t)])
=
1√
n
n∑
i=1
E[R(t)|Si]−
√
nE[R(t)].
Hence
Un,1(t) + Un,2(t) + Un,3(t)
=
1√
n
n∑
i=1
Ai
pi
(Ri(t)− E[R(t)|Si]) + 1√
n
n∑
i=1
E[R(t)|Si]−
√
nE[R(t)]
+
1√
n
n∑
i=1
(
Ai
pi
− 1)E[R(t)|Si]
=
1√
n
n∑
i=1
(
Ai
pi
Ri(t)− E[R(t)]
)
.
Proof of Theorem 2. Under simple randomization, the results described in Theorem 2 have
been proved by Reid (1981) for continuous survival functions. More generally, under simple
randomization, for survival functions that may have discontinuities, the results of Theorem
2 have been proved in Section 4.3 of Kosorok (2008). It remains to prove Theorem 2 under
stratified randomization and the biased-coin design, which we do below. Consider either
stratified randomization or the biased coin design, and consider any a ∈ {0, 1}.
We use Ŝ
(a)
n , Λ̂(a), N (a), L(a) to denote the processes {Ŝ(a)n (t) : t ∈ [0, τ ]}, {Λ̂(a)(t) :
t ∈ [0, τ ]}, {N (a)(t) : t ∈ [0, τ ]} and {L(a)(t) : t ∈ [0, τ ]} respectively. We define
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PnX =
1
n
∑n
i=1Xi for any random variable X and let D denote the space of real cad-
lag (right-continuous with left limit) functions with domain [0, τ ] with uniform norm. For
any sequence of process {Xn(t) : t ∈ [0, τ ]}, we denote Xn(t) = op∗(1) if, for any ε > 0,
limn→∞ P ∗(supt∈[0,τ ] |Xn(t)| > ε) = 0, where P ∗ represents the outer probability measure
(Section 6.2 of Kosorok 2008); that is, op∗(1) represents convergence to 0 in probability
uniformly over t ∈ [0, τ ].
This proof begins with showing that Λ̂(a) is asymptotically linear. Consider the following
derivation, which uses a general technique from the Appendix of Zhang (2015) and Chapter
4 of Kosorok (2008):
Λ̂(a)(t)− Λ(a)(t)
=
∫ t
0
PnI{A = a}dN (a)(t′)
PnI{A = a}I{U(a) ≥ t′} − Λ
(a)(t)
=
∫ t
0
PnI{A = a}dN (a)(t′)
PnI{A = a}I{U(a) ≥ t′} −
∫ t
0
PnI{A = a}I{U(a) ≥ t′}
PnI{A = a}I{U(a) ≥ t′}dΛ
(a)(t′)
−
∫ t
0
I{PnI{A = a}I{U(a) ≥ t′} = 0}dΛ(a)(t′)
=
∫ t
0
PnI{A = a}dL(a)(t′)
PnI{A = a}I{U(a) ≥ t′} −
∫ t
0
I{PnI{A = a}I{U(a) ≥ t′} = 0}dΛ(a)(t′)
= D
(a)
n,1(t) +D
(a)
n,2(t)−D(a)n,3(t),
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where
D
(a)
n,1(t) =
∫ t
0
PnI{A = a}dL(a)(t′)
piaP (U(a) ≥ t′) ,
D
(a)
n,2(t) =
∫ t
0
{
1
PnI{A = a}I{U(a) ≥ t′} −
1
piaP (U(a) ≥ t′)
}
· {PnI{A = a}dL(a)(t′)},
D
(a)
n,3(t) =
∫ t
0
I{PnI{A = a}I{U(a) ≥ t′} = 0}dΛ(a)(t′).
We next show D
(a)
n,2(t) = op∗(
1√
n
) using Lemma 4. Since L(a) is a function of U(a)
and δ(a), then Assumption 1’(i’) and stratified randomization (or the biased-coin design)
imply that (L
(a)
1 , . . . , L
(a)
n )⊥⊥(A1, . . . , An)|(S1, . . . , Sn). Defining L(s,a) as the conditional
process {L(a)(t)|(S = s) : t ∈ [0, τ ]} for each s ∈ S, then we have that L(s,a) is P-
Donsker by Lemmas 4.1 and Corollary 9.32 (i) of Kosorok (2008), since N (a)(t) ∈ D and∫ t
0
I{U(a) ≥ t′}dΛ(t′) ∈ D are monotone. Under stratified randomization or the biased-
coin design, we apply our Lemma 4 setting R = L(a) and get
√
n{PnI{A = a}L(a)(t) −
piaE[L
(a)(t)] : t ∈ [0, τ ]} weakly converges to a tight, mean 0 Gaussian process. Since
Theorem 1.3.2 of Fleming and Harrington (2011) implies that L(a) is a martingale, then
we have E[L(a)(t)] = 0 for each t ∈ [0, τ ] and hence the previous sentence implies that
PnI{A = a}L(a)(t) = op∗(1). By a similar argument, we have
√
nPn{I{A = a}I{U(a) ≥
t} − piaP (U(a) ≥ t) : t ∈ [0, τ ]} weakly converges to a tight, mean 0 Gaussian process.
Define Dφ = {f ∈ D : inft∈[0,τ ] |f(t)| > 0} and φ : Dφ 7→ D with φ(g) = 1/g. Then φ is
Hadamard-differentiable, tangentially to D (Page 22 of Kosorok, 2008). Since Assumption
1’ (iii’) implies that P (U(a) ≥ t) ∈ Dφ, then the functional delta method (Theorem 2.8 of
Kosorok, 2008) implies that the process
Z(a)n =
√
n{φ(PnI{A = a}I{U(a) ≥ t})− φ(piaP (U(a) ≥ t)) : t ∈ [0, τ ]}
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weakly converges to a process Z(a). Slutsky’s theorem (Theorem 7.15 of Kosorok, 2008)
shows that (Z
(a)
n ,PnI{A = a}L(a)) jointly converges to (Z(a), 0). Since the map (f, g) 7→
{∫ t
0
f(t′)dg(t′) : t ∈ [0, τ ]} is continuous for f, g ∈ D and g with bounded total variation,
using continuous mapping theorem letting f = Z
(a)
n and g = PnI{A = a}L(a), we have
√
nD
(a)
n,2(t) =
∫ t
0
Z
(a)
n (t′)PnI{A = a}dL(a)(t′) converges to 0 uniformly in t.
We then show D
(a)
n,3(t) = op∗(
1√
n
). Define In(t) = I{PnI{A = a}I{U(a) ≥ t} = 0}.
Then In(t) is an increasing function of t taking values on {0, 1}, which implies that, for
any ε ∈ (0, 1), P ∗(supt |
√
nIn(t)| > ε) = P ∗(supt |In(t)| = 1) = P (In(τ) = 1). Since
our arguments above imply that PnI{A = a}I{U(a) ≥ τ} = piaP (U(a) ≥ τ) + op∗(1)
and Assumption 1’ (iii’) implies P (U(a) ≥ τ) > 0, then P (In(τ) = 1) = P (PnI{A =
a}I{U(a) ≥ τ} = 0)→ 0. Hence In(t) = op∗( 1√n). Since
Λ(a)(t) ≤ Λ(a)(τ) = E
[∫ t
0
dN (a)(t′)
P (U(a) ≥ t′)
]
≤ E[N
(a)(τ)]
P (U(a) ≥ τ) <∞,
we get
D
(a)
n,3(t) =
∫ t
0
In(t
′)dΛ(a)(t′) =
∫ t
0
op∗(
1√
n
)dΛ(a)(t′) ≤ op∗( 1√
n
)Λ(a)(τ) = op∗(
1√
n
).
We have shown
√
n{Λ̂(a)(t)−Λ(a)(t)} = √nD(a)n,1(t)+op∗(1) =
1√
n
n∑
i=1
I{Ai = a}
pia
∫ t
0
dL
(a)
i (t
′)
P (Ui(a) ≥ t′) +op
∗(1),
which proves the asymptotic linearity of Λ̂(a).
We next show Ŝ
(a)
n is asymptotically linear and
√
n(Ŝ
(a)
n − S(a)0 ) converges weakly to a
mean 0, tight Gaussian process with covariance function V (a)(t, t′) defined in Section C.
Define Dψ = {f ∈ D :
∫ τ
0
|df(t′)| ≤ M} for a constant M > 0 large enough and product
integral map ψ : Dψ 7→ D with ψ(f)(t) =
∏
0<t′≤t(1 + df(t)). Then as shown by Kosorok
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(2008) in page 243, Ŝ
(a)
n = ψ(−Λ̂(a)) and S(a)0 = ψ(−Λ(a)). Lemma 12.5 of Kosorok (2008)
implies that ψ is Hadamard differentiable and we denote its derivative as ψ′f , which is a
continuous linear map from Dψ to D for f ∈ Dψ. Applying the Dugundji extension theorem
(Theorem 10.9 of Kosorok, 2008), we can extend ψ′f to be a continuous linear map from D to
D with the map on Dψ unchanged. Then Theorem 20.8 of van der Vaart (1998) implies that
√
n{Ŝ(a)n (t)− S(a)0 (t)} = ψ′−Λ(−
√
n{Λ̂(a)(t)−Λ(a)(t)}) + op∗(1). Since ψ′Λ is linear and con-
tinuous, we have ψ′−Λ(−
√
n{Λ̂(a)(t) − Λ(a)(t)}) = − 1√
n
∑n
i=1
I{Ai=a}
pia
ψ′−Λ
(∫ t
0
dL
(a)
i
(t′)
P (Ui(a)≥t′)
)
+
ψ′−Λ(op∗(1)), using the asymptotic linearity of Λ̂
(a)(t) proved above. Given the formula for
ψ′Λ in Lemma 12.5 of Kosorok (2008), we have ψ
′
−Λ
(∫ t
0
dL
(a)
i
(t′)
P (Ui(a)≥t′)
)
= S
(a)
0 (t)H
(a)
i (t) and
ψ′−Λ(op∗(1)) = op∗(1), where H
(a)
i (t) is defined in Section C. Hence we get
√
n{Ŝ(a)n (t)− S(a)0 (t)} = −
1√
n
n∑
i=1
I{Ai = a}
pia
S
(a)
0 (t)H
(a)
i (t) + op∗(1),
which proves the asymptotic linearity claimed in Theorem. To prove the weak convergence
result, we have E[H(a)(t)] = 0 for all t ∈ [0, τ ], using Fubini’s Theorem of interchangeability
of integrals (Lemma 1.2.7 of Vaart and Wellner, 1996). Since H(a)|(S = s) is a summation
of two bounded, monotone and cadlag processes, by Lemma 4.1 and Corollary 9.32 (i) of
Kosorok (2008), the class of functions {H(a)(t)|(S = s) : s ∈ S, t ∈ [0, τ ]} is P-Donsker.
Then we apply Lemma 4 and get the desired weak convergence of
√
n(Ŝ
(a)
n − S(a)0 ) to a
mean 0, tight Gaussian process with covariance function V (a)(t, t′).
We next show V (a)(t, t) ≤ V˜ (a)(t, t) for any t ∈ [0, τ ], where V (a)(t, t) is defined by
equation (2) of the Supplementary Material. Under simple randomization and Assumption
1’, Theorem 1 of Zhang (2015) gives that V˜ (a)(t, t) =
S
(a)
0 (t)
2
pia
V ar(H(a)(t)). Then
V˜ (a)(t, t)− V (a)(t, t) = S(a)0 (t)2
(1− pia)
pia
E{E[H(a)(t)|S]2} ≥ 0.
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Finally, we show that V (a)(t, t) is consistently estimated by equation (3). For B̂(a)(t),
direct calculation shows that
B̂(a)(t) = E
(a)
n,1(t) + E
(a)
n,2(t) + E
(a)
n,3(t),
where
E
(a)
n,1(t) =
∫ t
0
dΛ(a)(t′)
P (U(a) ≥ t′)(1−∆Λ(a)(t′)) ,
E
(a)
n,2(t) =
∫ t
0
{
1
P̂ (U(a) ≥ t′)(1−∆Λ̂(a)(t′))
− 1
P (U(a) ≥ t′)(1−∆Λ(a)(t′))
}
dΛ̂(a)(t′),
E
(a)
n,3(t) =
∫ t
0
d{Λ̂(a)(t′)− Λ(a)(t′)}
P (U(a) ≥ t′)(1−∆Λ(a)(t′)) .
For E
(a)
n,1(t), given Assumption 1’ (iii’), Theorem 2.6.2 of Fleming and Harrington (2011)
implies that H(a) is a martingale and V ar(H(a)(t)) = E
(a)
n,1(t).
For E
(a)
n,2(t), we first establish {∆Λ̂(a)(t) : t ∈ [0, τ ]} weakly converges to {∆Λ(a)(t) :
t ∈ [0, τ ]}. For each s ∈ S, since {I{U(a) ≥ t, δ(a) = 1}|(S = s) : t ∈ [0, τ ]} and
{I{U(a) ≤ t, δ(a) = 1}|(S = s) : t ∈ [0, τ ]} are P-Donsker and uniformly bounded, then
Corollary 9.32 of Kosorok (2008) implies that {I{U(a) = t, δ(a) = 1}|(S = s) : t ∈ [0, τ ]}
is P-Donsker. Since Assumption 1’ (iii’) implies that inft∈[0,τ ] P (U(a) > t) > 0, then
Lemma 4 and continuous mapping theorem (Theorem 7.7 of Kosorok, 2008) shows that
{∆Λ̂(a)(t) : t ∈ [0, τ ]} weakly converges to {∆Λ(a)(t) : t ∈ [0, τ ]}. Similarly, we have
{P̂ (U(a) ≥ t) : t ∈ [0, τ ]} weakly converges to {P (U(a) ≥ t) : t ∈ [0, τ ]}. Since Assumption
1’ (iii’) also implies that supt∈[0,τ ]∆Λ
(a)(t) < 1, by the continuous mapping theorem, we
get ∣∣∣∣ 1
P̂ (U(a) ≥ t′)(1−∆Λ̂(a)(t′))
− 1
P (U(a) ≥ t′)(1−∆Λ(a)(t′))
∣∣∣∣ = op∗(1).
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Then
|E(a)n,2(t)| ≤
∫ t
0
∣∣∣∣ 1
P̂ (U(a) ≥ t′)2(1−∆Λ̂(a)(t′))
− 1
P (U(a) ≥ t′)2(1−∆Λ(a)(t′))
∣∣∣∣dΛ̂(a)(t′)
= op∗(1)Λ̂
(a)(t).
Since we have shown that Λ̂(a)(t) = Λ(a)(t) + op∗(1) and Λ
(a)(t) is uniformly bounded, we
get E
(a)
n,2(t) = op∗(1).
For E
(a)
n,3(t), we define T = {t ∈ [0, τ ] : ∆Λ(a)(t) > 0} as the set of jump points of Λ(a)(t).
Since Λ(a)(t) is monotone in t, then T is a countable set. Consider the following derivation:
E
(a)
n,3(t) =
∫ t
0
d{Λ̂(a)(t′)− Λ(a)(t′)}
P (U(a) ≥ t′) +
∫ t
0
∆Λ(a)(t′)d{Λ̂(a)(t′)− Λ(a)(t′)}
P (U(a) ≥ t′)(1−∆Λ(a)(t′))
=
∫ t
0
d{Λ̂(a)(t′)− Λ(a)(t′)}
P (U(a) ≥ t′) (8)
+
∑
t′∈T∩[0,t]
∆Λ(a)(t′){∆Λ̂(a)(t′)−∆Λ(a)(t′)}
P (U(a) ≥ t′)(1−∆Λ(a)(t′)) . (9)
For quantity (8), since the map g 7→ {∫ t
0
dg(t′)
P (U(a)≥t′) : t ∈ [0, τ ]} is continuous for g ∈ D with
bounded total variation, by the continuous mapping theorem, we have
∫ t
0
d{Λ̂(a)(t′)−Λ(a)(t′)}
P (U(a)≥t′) =
op∗(1). For quantity (9), we have
sup
t∈[0,τ ]
∣∣∣∣ ∑
t′∈T∩[0,t]
∆Λ(a)(t′){∆Λ̂(a)(t′)−∆Λ(a)(t′)}
P (U(a) ≥ t′)(1−∆Λ(a)(t′))
∣∣∣∣
≤
∑
t′∈T
∆Λ(a)(t′)|∆Λ̂(a)(t′)−∆Λ(a)(t′)|
P (U(a) ≥ τ)(1− supt′∈[0,τ ]∆Λ(a)(t′))
≤ Λ
(a)(τ) supt′∈[0,τ ] |∆Λ̂(a)(t′)−∆Λ(a)(t′)|
P (U(a) ≥ τ)(1− supt′∈[0,τ ]∆Λ(a)(t′))
.
Since Λ(a)(τ) <∞, supt′∈[0,τ ]∆Λ(a)(t′) < 1 and ∆Λ̂(a)(t′)−∆Λ(a)(t′) = op∗(1), then we get
(9) = op∗(1). Hence E
(a)
n,3(t) = op∗(1).
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Combination of the above derivations shows that B̂(a)(t) = V ar(H(a)(t)) + op∗(1). Fol-
lowing a similar proof, we can show that∑n
i=1 I{Si = s}Ĥ(a)i (t)∑n
i=1 I{Si = s}
= E[H(a)(t)|S = s] + op∗(1).
Since we have shown that Ŝ
(a)
n (t) = S
(a)
0 (t) + op∗(1), by the functional continuous mapping
theorem, we have
V̂ (a)(t, t) =
S
(a)
0 (t)
2
pia
[V ar(H(a)(t))− V ar(E[H(a)(t)|S])] + op∗(1)
= V (a)(t, t) + op∗(1).
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